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Abstract
Ellis, David H. Ph.D. Biomedical Sciences Ph.D. Program, Wright State University,
2015. Silver nanoparticles: the immediate benefits of low bacterial resistance and the
long-term risk of persistent stress in mammalian cell

Silver nanoparticles (AgNPs) are the fastest growing sector of nanotechnology,
due mostly to their antibacterial properties. The antibacterial effectiveness of AgNPs is
well known and derives from the shedding of silver ions which have multiple
antibacterial targets in the bacterial cell. Due to their continuous release of ions and
demonstrated antibacterial potency, some predict that AgNPs have a low potential for
resistance development, which would make them a valuable asset in wound management.
The ability for AgNPs to cause oxidative imbalance in mammalian cells is also well
known, but the potential long-term impact of such a stress has not been studied despite its
implication for negative outcomes in wound management. In this thesis, I demonstrate by
using a stepwise increasing exposure protocol that Pseudomonas aeruginosa, but not
Acinetobacter baumannii or Staphylococcus aureus could develop resistance to 10 nm,
citrate-coated AgNPs. The potential for resistance development was lower than the
antibacterial drug, ciprofloxacin, but not as low as silver nitrate to which none of the
bacteria developed resistance. The resistance mechanism is not yet clear but appeared to
involve the phenazine pigments produced by P. aeruginosa which can bind and reduce
silver ions. In mammalian cells, I demonstrated the persistence and time-dependent
oxidative stress of AgNPs in the A549, epithelial cell model, by using specialized
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imaging techniques and a common probe for oxidative stress. In addition, I showed that
AgNPs can induce a senescent-like phenotype in A549 cells after an exposure that
appears non-toxic in the typical viability assays used for assessing cytotoxicity. I
confirmed that senescence was induced by showing an increase in senescence-associated,
beta-galactosidase activity and the hypertrophic morphology of exposed cells, as well as
a decrease in proliferation. The implication of this research for wound management is
that AgNPs can be properly applied to wounds in order to inhibit bacterial colonization
with little potential for resistant strains to emerge; however, the nanoparticles may persist
in wound-associated, mammalian cells. There, the AgNPs will cause persistent oxidative
stress with the potential to induce cellular senescence and reduce the long-term health
and function of the surrounding tissue.
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INTRODUCTION
Nanotechnology
Nanotechnology is the manipulation of materials at the nanometer scale. A
nanometer is 10-9 meters and nanomaterials (NMs) are defined as having at least one
dimension less than 100 nm, which is around one hundred times smaller than the width of
a human hair. The impetus for manipulating materials at such a small scale is credited to
Richard Feynman from a 1959 presentation entitled, “There’s Plenty of Room at the
Bottom” (Feynman 1959). The term nanotechnology, however, did not emerge until 1974
in Norio Taniguchi’s review of semiconductor engineering(Taniguchi 1974). The
emergence of the nanotechnology industry might be traced to the Nobel Award winning
discovery of the fullerene by Richard Smalley in 1985 (Kroto et al. 1985) or the first
reported manipulation of material at the atomic level by Eigler and Schweizer in 1990
(Eigler & Schweizer 1990) or even the first detailed characterization of carbon nanotubes
in 1991 by Iijima (Iijima 1991). The industry boom, however, didn’t begin until after the
National Science and Technology Council released a report in 1999 on the future of
nanotechnology (Roco & Williams 1999). The report spurred formation of the National
Nanotechnology Initiative in 2000, aimed at stimulating advancements in the burgeoning
field. Just over a decade later, the Initiative reported that annual spending on
nanotechnology was nearly 2 billion U. S. dollars in the United States, 44 million in
Brazil, 600 million in the European Union, and about 60 million in India (Baucher et al.
2013). According to The Project on Emerging Nanotechnologies, the number of
consumer products that claim to use nanomaterials has grown from 54 in 2005 to more
1

than 1600 in 2013 (Project on Emerging Nanotechnologies 2013). The products come
from a broad range of categories including home appliances (laundry, heating, cooling,
and kitchen), the automotive industry (parts, maintenance, and lubrication), electronics
(batteries, computers, mobile devices, and televisions), foods and beverages
(supplements, coloring, storage, and cooking), health and fitness (clothing, cosmetics,
filtration, personal care, sporting goods, and sunscreen), as well as general home and
garden products (cleaning, construction, and paints). This dramatic increase in research,
manufacturing, and use of NMs translates to an increase in human exposure.
Unfortunately, like most novel technologies, the industry grew faster than our knowledge
about the health effects of nanomaterials. Great concern has risen over the safety of
nanometer sized carbon and inorganic metal particles because the very properties that
distinguish them from their bulk counterparts may cause detrimental effects not revealed
by historical studies of the bulk materials (Oberdörster et al. 2005). In fact, NMs have
some of the same properties of bulk materials but have more surface atoms per unit mass
allowing greater influence by quantum mechanics and causing changes in spectral
properties, heat and electrical conduction, and their reactivity with other molecules
(Feynman 1959). In fact, their minute size and high reactive surface area may promote
cellular uptake and deleterious interaction with biomolecules (Powell & Kanarek 2006).
While nanometer-sized particulates are probably ubiquitous and humans have been
exposed to them throughout history, the increased engineering and purposeful use of
nanoparticles has magnified that exposure. The realization of that potential hazard has
greatly expanded study into the health effects of NMs and spawned the field of
nanotoxicology (Oberdörster et al. 2005).
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Silver nanoparticles in wound management
The fastest growing sector of nanotechnology is AgNPs, due mainly to their
antibacterial properties which are exploited in over 200 registered consumer products
including wound dressings, personal care products, sheets, towels, clothing, toys and
products for infants, food containers, laundry products, health drinks, cleaning sprays, air
purifiers and humidifiers, and paints and coatings on various large and small appliances
like laundry machines, refrigerators, haircare tools, and computer peripherals (Nowack et
al. 2011; Project on Emerging Nanotechnologies 2013). The surface of AgNPs are known
to become oxidized in solution, which facilitates the release of ionic silver (Ag+) at a rate
that depends upon the particle’s size and surface coating and the pH and dissolved
oxygen content of the solution (Kittler et al. 2010; Liu & Hurt 2010; Maurer et al. 2014;
Xiu et al. 2011). The antibacterial properties of Ag+ are well recognized and have been
exploited for centuries in water purification, wound care, and dietary supplements to
bolster immunity, and so the discovery that AgNPs are bactericidal was not surprising
(Kim et al. 2007; Silver et al. 2006). The proposed advantage of using AgNPs over the
more common sources of Ag+, such as silver nitrate (AgNO3) or silver sulfadiazine, is in
the slower release of Ag+ from AgNPs which is expected to provides antibacterial
protection for an extended period, allowing less frequent changing of the dressing, which
prevents disruption of the healing tissue and increases the rate of wound closure (Atiyeh
et al. 2007). Counting on that supposition, at least two commercial wound dressings have
been produced which contain AgNPs: Acticoat® (Smith & Nephew, Hull, UK) and
PolyMem Silver (Ferris Mfg. Corp., Burr Ridge, IL). PolyMem incorporates metallic
silver particles into their standard foam dressing while Acticoat is made by depositing
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silver atoms directly on a membrane using physical vapor deposition (Dunn & EdwardsJones 2004). Atomic force microscopy (Bianco et al. 2015) and scanning electron
microscopy (Dunn & Edwards-Jones 2004) of the silver layer of Acticoat have revealed
an intricate nano-topography on the surface of the membrane with vertical displacements
between 16 and 120 nm and horizontal widths of about 15 nm; however, the nanotopology is created as a layer on the membrane and appears in cross-section as
projections from the surface, and so the claim of using nanoparticles might be somewhat
misleading. Nevertheless, Acticoat, is reported to releases Ag+ into liquid media for an
extended period of time owing to its nano-architecture (Dunn & Edwards-Jones 2004).
The antibacterial efficacy of Acticoat in vitro and its superiority over dressings that
contain other forms of silver have been well documented (Castellano et al. 2007; Ip et al.
2006; Ulkür et al. 2005). More importantly, both animal models (Olson et al. 2000;
Wright et al. 2002) and human studies (Demling & DeSanti 2002; Dunn & EdwardsJones 2004) have demonstrated more rapid healing through reduced bacterial
colonization, reduced inflammation, and increased re-epithelization. Unfortunately, none
of the studies already cited followed the wounds to complete resolution. In one study that
did follow wounds to their complete resolution, two patients had to be switched to
another dressing because Acticoat failed to induce any signs of wound closure (Innes et
al. 2001). In that study, a similar dressing that did not contain silver outperformed
Acticoat in every measure of wound healing, and another study (Ozaki et al. 2015)
reported that there was no advantage to using Acticoat over a dressing that did not
contain silver. In early in vitro studies that were based on cellular metabolic activity,
Acticoat was reported to be cytotoxic to keratinocytes and fibroblasts (Paddle-Ledinek et
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al. 2006; Poon & Burd 2004), but more recently, metabolic activity was shown to be
reduced in fibroblasts while the cells remained viable (Rigo et al. 2013). In other studies,
the silver from Acticoat reached systemic circulation without causing any detrimental
effects (Vlachou et al. 2007), but caused reversible liver toxicity when the blood
concentrations reached 100 g/ml in a patient with mixed depth burns over 30% of his
body (Trop et al. 2006). Mixed results have also been reported for PolyMem Silver,
silver-containing hydrogels, and the direct application of silver nanoparticles to
experimental wounds (Boonkaew, Kempf, Kimble, Supaphol, et al. 2014; Boonkaew,
Barber, et al. 2014; Boonkaew, Kempf, Kimble & Cuttle 2014; Chowdhury et al. 2014;
Jain et al. 2009). The mix of positive reports such as inhibiting bacterial colonization and
an increased rate of wound healing and negative effects such as cytotoxicity and inhibited
wound closure, leaves one to question the benefit of AgNPs in wound management.

The cellular effects of silver nanoparticles
The potential for AgNPs to cause cellular toxicity in vitro has been well
documented. The effect most often reported in mammalian cell lines is oxidative stress
(Comfort et al. 2011; Foldbjerg et al. 2011; Kawata et al. 2009; Kim et al. 2009) which
has been linked to lipid and DNA damage in vitro and also in animal models (Ahamed et
al. 2008; Arora et al. 2008; AshaRani, Low Kah Mun, et al. 2009; Ghosh et al. 2012).
Interestingly, the typical cytotoxicity study involves a relatively short exposure (up to 24
hours) followed by an immediate assessment for overt signs of toxicity, but animal
models have shown that AgNPs distribute to many different tissues regardless of the
exposure route, and are persistent in those tissues. Relatively high concentrations of silver
(0.1 – 3 g/g tissue) have been reported in the liver, kidney, lung, brain, and hind-leg
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muscle of rats after 28 daily doses by oral gavage (Loeschner et al. 2011). Similar
concentrations (0.2 – 0.6 g/g tissue) were reported in the same tissues 28 days after a
single intravenous dose (Dziendzikowska et al. 2012). The concentration of silver in the
kidney after an intravenous dose was still high on day 28 even though the urinary
excretion of silver was maximal at day 5, which suggests that the silver was not only
secreted by the kidney but was sequestered in the tissues. Persistent concentrations of
silver were also reported in the lungs (98 ng/g tissue) and liver (3 ng/g tissue), 7 days
after a single inhalation exposure to AgNPs (Takenaka et al. 2001). The persistent
presence of silver in those tissues is likely a source of persistent oxidative stress, because
the particles themselves have been linked to oxidative stress and they can release Ag+
which also causes stress by binding sulfhydryl groups and creating an imbalance in thiolmediated, reduction and oxidation (redox) homeostasis (Baldi et al. 1988). In humans,
there are few studies into the effects of AgNPs. In the studies already mentioned
regarding the use of Acticoat, only two studies measured effects outside the wound area:
blood concentrations and liver toxicity associated with high blood concentrations. One
clinical study has been reported in which a commercial solution of colloidal silver was
administered in daily oral doses to human subjects for up to 14 days (Munger et al. 2014).
There was no evidence of toxicity in that study; however, the colloidal solution was made
by electrolysis of water using silver electrodes and analytical analysis revealed that Ag+
accounted for 84% of the total silver, and so the subjects were actially exposed to
relatively small doses of AgNPs. Historically, the only negative effect associated with
Ag+ in humans is argyria, a blue and grey discoloration of tissue (Drake & Hazelwood
2005), which was also reported in the Acticoat studies already discussed. The
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discoloration is likely produced by deposits of insoluble silver salts, like silver sulfide,
which have been found in the biopsies of discolored skin (Westhofen & Schäfer 1986).
That silver is presumed to be unavailable for further reaction and probably explains the
low incidence of toxicity associated with solutions that are mainly composed of Ag+. In
fact, the difference between Ag+ and AgNPs is that the Ag+ can become immobilized
immediately upon entering a tissue, but AgNPs can be internalized by the cells and then
release Ag+ in a “Trojan-horse” style of toxicity (Park, et al., 2010). That slow release of
Ag+ may cause persistent oxidative stress and produce long-term toxicity that has not
been studied extensively with regard to AgNPs. During wound treatment, cells within the
tissue surrounding the wound site are exposed to AgNPs for several days and might
internalize an appreciable amount of the particles. Long-term effects, such as redox
imbalance, might have serious implications for the ability of that tissue to properly heal
and for its long-term health. One potential consequence of long-term oxidative stress is
the induction of cellular senescence. Cellular senescence is a natural process by which
cells enter a state of permanent growth arrest (Hayflick 1965), but it can also be induced
prematurely by oxidative stress (Toussaint et al. 2000). Functional changes associated
with cellular senescence include the persistent secretion of inflammatory cytokines,
changes in attachment protein expression, and altered cellular differentiation (Coppe et
al. 2008; Maier et al. 1993; Saunders et al. 1993). Those changes can cause suboptimal
cell or tissue function, inhibit the self-repair of tissues, or even cause chronic
inflammation which can contribute to osteoporosis, osteoarthritis, atherosclerosis, and
cancer (Campisi et al. 2011; Freund et al. 2010; Wang et al. 2010). Jun and Lau (Jun &
Lau 2010a) have postulated a role for senescence in wound healing based on their own
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study which suggested that myofibroblast cells were inactivated by the induction of
cellular senescence (Jun & Lau 2010b). The study, however, did not convincingly rule
out quiescence, which is reversible cell-cycle arrest, instead of senescence, and their
theory contradicts a well-established wound-healing model (Desmouliere et al. 1995). In
the established model, myofibroblast cells continue to secrete extracellular matrix to
close the wound and chemoattractant to recruit immune cells until the myofibroblasts
undergo apoptosis. The cells in Jun and Lau’s study would not have entered senescence
prior to apoptosis because senescent cells are resistant to apoptosis (Al-Mohanna et al.
2004; Wang 1995). Jun and Lau recognized senescence by senescence associated galactosidase activity, which has been reported in quiescent as well as senescent cells
(Severino et al. 2000) and by expression of p16INK4a protein which can be induced by
TGF- (Vijayachandra et al. 2009), but TGF- is also involved in the differentiation of
fibroblast to myofibroblast cells (Xu et al. 2012). Jun and Lau, therefore, may have
mistaken the differentiation of fibroblasts into myofibroblasts for cellular senescence.
Senescence is more likely to interfere with wound healing than to encourage it because
senescence causes chronic inflammation which ultimately inhibits proper wound
resolution (Martin & Leibovich 2005). If silver nanoparticles induce senescence, then
they might inhibit proper wound resolution. The potential for AgNPs to induce
senescence has not been reported to date; however, senescence is a programed response
which develops over a period of time and would not be detected in a typical, short-term
cytotoxicity assay. Two studies have suggested that AgNPs have a long-term effect on
cell proliferation. Zanette, et. al. (Zanette et al. 2011) claimed that AgNPs inhibited
HaCaT proliferation for up to 6 days following a 24-hour exposure, but their conclusion
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is not convincing because they measured total protein content and metabolic activity to
indicate proliferation instead of cell counts or growth rate, and their culture images
clearly showed that the cell density was different between treatments. Never-the-less,
they did demonstrate that AgNPs had a long-term effect (reduced metabolic activity) that
was not apparent until 6 days after the exposure ended. AshaRani, et. al. (AshaRani,
Hande, et al. 2009) demonstrated that exposure to AgNPs caused a delay in the time it
took normal human lung fibroblast cells and human glioblastoma cells to reach
confluence. The delay, however, may have been caused by a dramatic reduction in cell
density during exposure because the concentrations were relatively high (≥ 200 g/ml).
Unfortunately, the toxic effect immediately after exposure was not described and the
mechanism of inhibition was not studied. The potential for AgNPs to induce cellular
senescence would be better evaluated using an exposure that does not cause obvious, or
overt toxicity, and that was the goal of the first section of this thesis. In this study, AgNPs
induced a senescent-like phenotype in A549 cells, a pulmonary epithelial cell line. The
phenotype was induced over time, after an exposure that did not cause overt toxicity (10
g/ml for 24 hours). These results suggest a potential for AgNPs to induce cellular
senescence which is likely to interfere with proper wound resolution; however, that
negative effect must be weighed against potential benefits related to their antibacterial
activity before speculating on the overall value of AgNPs in wound management.

The antibacterial properties of silver nanoparticles
The use of Ag+ as an antibacterial agent has a long history, and some argue that
AgNPs have a long history of use but that their presence in silver products was simply
not recognized (Nowack et al. 2011). The activity of AgNPs against a broad spectrum of
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bacteria including Gram negative and Gram positive organisms, and antibiotic resistant
bacteria, has proven consistent regardless of what coating was used to stabilize them,
making AgNPs a valuable asset for preventing bacterial infection (Ansari et al. 2011;
Khan et al. 2014; Panacek et al. 2006; Pasupuleti et al. 2013; Sharma et al. 2009). The
antibacterial potency of AgNPs increases as the particle diameter decreases (Morones et
al. 2005; Samberg et al. 2011), which correlates with a greater release of Ag+ from
smaller particles (Sotiriou et al. 2012; Zhang et al. 2011). Despite the well characterized
release of Ag+ from AgNPs and recognized importance of Ag+ as an antibacterial agent,
there is still some debate over the dependence of AgNPs on Ag+ for bactericidal activity.
The argument against dependence on Ag+ is based on AgNPs still being able to inhibit
bacteria when the amount of released Ag+ that was measured in the medium was not
sufficient for antibacterial activity (Amato et al. 2011; Fabrega et al. 2009; Sondi &
Salopek-Sondi 2004; Taglietti et al. 2012). The studies which support that statement,
however, did not use the same conditions for studying dissolution and bacterial inhibition
so that the effects of agglomeration, salt content, reactive surface area, and the bacteria
themselves were not taken into account. Another, more convincing study demonstrated
that antibacterial efficacy correlated with Ag+ release (Xiu et al. 2012). When the AgNPs
were synthesized under anaerobic conditions and exposed to oxygen for defined periods
of time, the amount of Ag+ released correlated directly with how long the AgNPs were
exposed to oxygen, and the magnitude to which E. coli was inhibited correlated with the
amount of Ag+ released. In fact, the AgNPs did not release Ag+ and were unable to
inhibit the bacteria when maintained under anaerobic conditions. The antibacterial
efficacy of AgNPs, therefore, appears to depend on the release of Ag+, and that
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supposition is further supported by the studies that have identified the same mechanisms
of action to both Ag+ and AgNPs (see the next paragraph) even though some of the
targets are inside the cell where AgNPs have limited access. In mammalian cells,
particles are internalized by energy-dependent endocytosis, but bacteria, except for one
example in the budding bacterium, Gemmata obscuriglobus (Fuerst & Sagulenko 2010),
do not have endocytic machinery. The particle must pass through the bacterial cell
membrane, but that is unlikely due to their size and surface charge. Gram negative
bacteria also have an outer membrane barrier through which sugars, ions, and amino
acids can pass using channels formed by outer membrane porin proteins (Opr). The
channels can be substrate specific like phage-lambda-receptor-protein (LamB) which is a
maltose-specific porin in Escherichia coli (Van Gelder et al. 2002), or general like outermembrane-protein A (OmpA) which has homologs in many bacterial species (Hancock &
Brinkman 2002). Most of the general porins provide channels for the passage of 0.5 to
1.5 kDa molecules; however, molecules as large as 3.0 kDa can pass through the
Pseudomonas OprF (Hancock & Brinkman 2002). The Dalton is a 3-dimensional unit
and does not convert directly into the 2-dimensional unit of nanometers, but using Yoon’s
approximate correlation (Yoon 2011), the size of particles that can pass through the
porins ranges from 1.2 to 2.5 nm. That correlation between Daltons and nanometers is
confirmed by sugar-diffusion studies which suggest that OmpAAb from Acinetobacter
baumannii allows the passage of 1,000 Dalton sugar molecules that are about 2 nm in
size (Sugawara & Nikaido 2012; Nikaido et al. 1991). The potential for pores with
openings up to 2.5 nm in diameter means that the smallest nanoparticles might pass
through the Gram negative outer membrane, but they will still be excluded by the cell
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membrane, the only membrane barrier in Gram positive bacteria and the inner membrane
barrier in Gram negative bacteria. Ions can cross the cell membrane through ion-specific
channels or by facilitated transport, but no studies that address the transport of Ag+ into
bacterial cells have been reported, and so the transport method for internalization of Ag+
is unknown at this time. The Ag+ may be able to utilize the same uptake pathway as other
cations, or it might be internalized during the protein-mediated uptake of essential metals.
For example, both Gram negative and positive bacteria utilize siderophore proteins for
the uptake of ferrous iron (Fe3+) (Brown & Holden 2002; Cartron et al. 2006), and one
such protein, pyochelin from P. aeruginosa, has been shown to bind Ag+ (Braud et al.
2009), but the internalization of Ag+ bound by siderophores has not been reported. Only
the specific export of Ag+ has been studied and that has been most extensively studied in
association with “Sil” proteins which were discovered on the plasmid pMG101, that
conferred silver-resistance to Salmonella typhimurium in silver-treated burn wounds
(Gupta et al. 1999; Larkin McHugh et al. 1975). The association of silver uptake with
antibacterial efficacy and the ability of some bacteria to accumulate silver from the
environment (Slawson et al. 1990) suggests that a pathway for Ag+ to cross the cell
membrane does exist. On the other hand, the internalization of AgNPs has only been
reported in combination with damage that compromised the integrity of the bacterial
membrane (Li et al. 2010; Mei et al. 2014).
The reported antibacterial mechanisms for Ag+ include membrane damage (Jung
et al. 2008; Taglietti et al. 2012), inhibiting aerobic respiration (Bragg & Rainnie 1974;
Gordon et al. 2010; Holt & Bard 2005; Yamanaka et al. 2005), the binding and
condensation of DNA (Hossain & Huq 2002; Feng et al. 2000; Morones et al. 2005;
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Taglietti et al. 2012) and inducing oxidative stress (Park et al. 2009; Gordon et al. 2010).
Likewise, AgNPs have been shown to affect membrane integrity (Li et al. 2011; Lok et
al. 2006; Mirzajani et al. 2011; Morones et al. 2005; Taglietti et al. 2012), inhibit aerobic
respiration (Du et al. 2012), bind to isolated DNA (Yang et al. 2009), and cause oxidative
stress (Choi & Hu 2008; Kim et al. 2007; Hwang et al. 2008). As discussed in the
preceding paragraph, the bacteria are more likely to internalize Ag+ than AgNPs, and so
if the AgNPs themselves have an effect on the bacterial cells, they most likely attack the
cell membrane while the Ag+ that they release may enter the cells and attack intracellular
targets. Li, et. al., have shown a concentration-dependent delineation of the effects of
AgNPs in E. coli (Li et al. 2010) and S. aureus (Li et al. 2011), indicating that membrane
damage is the primary mechanism. Taglietti, et. al. (Taglietti et al. 2012), re-affirmed that
conclusion by showing that membrane damage is the most sensitive indicator, occurring
at half the minimum inhibitory concentration (MIC) in E. coli. Hwang, et. al. (Hwang et
al. 2008), reported that superoxide-based stress and membrane damage were equally
important in the antibacterial mechanism of AgNPs. They used E. coli that were
transfected with bioluminescent reporters specific for membrane damage, superoxidebased stress, peroxide-based stress, or DNA damage, and suggested that their results
indicated the simultaneous action of AgNPs on the membrane and Ag+ on the electrontransport enzymes. The researchers strengthened support for their theory by
demonstrating that AgNPs do not have synergistic activity with other membrane-active
agents (Triton X100 and ampicillin) or with agents that target the ribosomes inside the
cell (chloramphenicol and kanamycin), but act synergistically with the energy inhibitors,
sodium azide and N,N-9-dicyclohexylcarbodiimide, suggesting that Ag+ which can
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inhibit the electron transport enzymes was compounding the inhibition of energy
production (Hwang et al. 2012). Based on the idea that AgNPs have multiple targets for
bactericidal activity and that they are a continuous source of Ag+, which has multiple
cellular targets, and that resistance which requires multiple changes to the bacterial
phenotype is less likely to develop (Hooper 2001), some have proposed that bacteria are
less likely to develop resistance to AgNPs than to antibacterial drugs (Pelgrift &
Friedman 2013; Percival et al. 2005). Never-the-less, resistance to Ag+ has been reported
in Enterobacter cloacae and Pseudomonas stutzeri that were isolated from silver-rich
environments (Haefeli et al. 1984; Nakahara et al. 1989), and in Salmonella typhimurium
and Pseudomonas aeruginosa isolated from silver-treated burn wounds (Larkin McHugh
et al. 1975; Bridges et al. 1979). Increasing tolerance to Ag+ has also been reported in E.
coli after stepwise exposure (Li et al. 1997). The resistance is typically mediated by
efflux of Ag+ (Gupta et al. 1999), but the genes known to encode silver-binding and
efflux proteins are rare (Percival et al. 2008) and may not be sufficient to protect the
bacterium from exposure to silver (Woods et al. 2009). Expression of the plasmidencoded genes for efflux systems and changes in the permeability of the cell membrane
to reduce the amount of silver taken up by cells may both be necessary for effective silver
resistance (Starodub & Trevors 1990; Slawson et al. 1990). Moreover, assuming that the
AgNPs affect the bacterial membrane directly, they would be unaffected by the efflux
systems that offer some protection from silver. If the predicted, low potential for
resistance development is accurate, AgNPs would have a high value in wound
management, especially in environments where inhibiting bacterial infection during the
initial wound treatment may be critical for proper resolution, and where follow-up
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treatment to prevent infection is often delayed, for example during military engagements
(Murray 2008; O’Shea 2012). The goal of the second section of this thesis was to
determine the potential for bacteria to develop resistance to AgNPs compared to
ciprofloxacin, a potent, quinolone, antibacterial drug, and benzalkonium chloride, a
membrane-active biocide. This study discovered that P. aeruginosa could rapidly develop
resistance to AgNP or ciprofloxacin but not benzalkonium chloride, and S. aureus and A.
baumannii could only develop resistance to ciprofloxacin. The mechanism of AgNPresistance is not yet clear but appears to be related to the production of phenazine
pigments which can bind or reduce Ag+, rendering it biologically unavailable.
These combined studies reveal that AgNPs have advantages and disadvantages for
use in wound management. They are effective antibacterial agents with a low potential
for bacteria to develop resistance, except for P. aeruginosa which can be effectively
inhibited by AgNPs, but can develop resistance when the concentration of particles
become sufficiently low. The AgNPs also have the potential to cause long-term oxidative
stress in mammalian tissue that they penetrate, which can degrade the long-term health of
the tissues and induce cellular senescence. Interestingly, the bacteria were unable to
develop resistance to Ag+ and silver in that form is less likely to cause cellular toxicity
due to its rapid salting-out in tissues. Perhaps the key to effective wound management is
embedding AgNPs in a dressing so that a sufficient amount of Ag+ is released to the
wound site to inhibit bacterial growth over an extended period of time, but the particles
themselves would not be taken up by mammalian cells. Such an approach might be
accomplished by enclosing the particles in a membrane that will allow fluid to enter and
only the Ag+ dissolved in that fluid to escape.
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SECTION 1: THE POTENTIAL LONG-TERM EFFECT OF
SILVER NANOPARTICLES ON MAMMALIAN CELLS
Summary:
Silver nanoparticles induce a senescent-like phenotype in A549 epithelial cells
following an exposure that does not cause overt cytotoxicity.
In order to determine if AgNPs induce premature cellular senescence, I exposed
the pulmonary epithelial cell line, A549 cells, to AgNPs at a dose that did not cause overt
toxicity (10 g/ml) for 24 hours and then the AgNPs were removed. After three days,
many of the cells displayed markers for cellular senescence including the expression of
senescence associated -galactosidase activity (SA--Gal), a large flat morphology, and a
slight decrease in the rate of proliferation. Senescence was most likely induced by
oxidative stress which was apparent 2-days after exposure to AgNPs and increased in
magnitude thereafter. Less than 50% of the exposed cells exhibited a senescent
phenotype, and that was probably due to the cancer-dereived, A549 cells which are
resistant to senescence; however, the ability of AgNPs to induce a senescence-like
phenotype in cells that are resistant to senescence is highly supportive of their ability to
induce premature cellular senescence in normal mammalian cells. If a wound is treated
with AgNPs and the cells internalize those particles, they will likely experience long-term
oxidative stress and become senescent, which could interfere with wound healing.
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Materials and Methods
Chemicals and reagents: The 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA)
and 4′,6-diamidino-2-phenylindole (DAPI) and paraformaldehyde were from Life
Technologies (Grand Island, NY). The Live-Dead Cell Staining Kit was from Biovision
(Mountain View, CA) and the MTS assay was the CellTiter 96 AQueous One Solution Cell
Proliferation Assay form Promega (Madison, WI). The Senescence Cells Histochemical
Staining Kit, Doxorubicin (DOX), N-acetyl cysteine (NAC), and hydrogen peroxide
(H2O2) were was from Sigma (Saint Louis, MO). The Quantitative Cellular Senescence
Assay Kit was from Cell Biolabs (San Diego, CA). The RPMI 1640 medium was from
ATCC. The Penicillin and Streptomycin solution (Pen/Strep), trypsin solution (0.25%),
fetal bovine solution (FBS) and Dulbecco’s Phosphate Buffered Saline (DPBS) were
from Hyclone Laboratories (Logan, UT).
The source and characterization of AgNPs: Biopure, citrate-stabilized, 10 nm AgNPs
were purchased form nanoComposix (San Diego, CA). The particles were chosen
because they typically have a small size distribution and their small size increases the
likelihood of observing an effect due to the known, size-dependent cytotoxicity of AgNPs
(Braydich-Stolle et al. 2010; Carlson et al. 2008; Gliga et al. 2014). The primary size and
shape of the AgNPS were estimated by absorption spectroscopy based on surface
plasmon absorption and then more accurately measured by transmission electron
microscopy (TEM). The AgNPs were diluted to 50 g/ml in water and then the
absorption spectrum of 0.1 ml was measured using a Synergy HT Spectrophotometer
Plate Reader (BioTek Instruments, Winooski, VT) and 0.005 ml was transferred to a
Formvar carbon-coated, copper TEM grid (Electron Microscopy Sciences) and allowed
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to air dry. Images of the particles were then captured using a Hitachi H-7600 TEM. The
diameter of AgNPs were measured using ImageJ software (NIH) which was calibrated to
the scale bar generated by the microscope. The hydrodynamic diameter and zeta
potential, or relative surface charge, of the particles was measured in water and growth
medium at 50 g/ml using dynamic light scattering (DLS) and laser Doppler microelectrophoresis in a ZetaSizer Nano (Malvern Instruments).
The cell model: The A549 cell line (ATCC CCL-185) was chosen for this study because
it represents a population of cells whose entrance into senescence might severely reduce
tissue function. The cells were derived from a human, alveolar cell carcinoma and are
similar to type II alveolar epithelial cells which have important roles in alveolar function
and are progenitor cells involved in repair of the alveolar epithelium (Barar et al. 2007;
Fehrenbach 2001; Foster et al. 1998; Lieber et al. 1976). The A549 cells were cultured in
RPMI 1640 medium, which was supplemented with 10% (v/v) FBS and 1% (v/v)
antibiotics, in a humidified, water-jacketed incubator at 37 C and 5% CO2.
The overt cytotoxicity of AgNPs: The overt cytotoxicity of the AgNPs was assessed by
measuring metabolic activity using the MTS assay and by viability using the Live-Dead
Cell Staining Kit (Live-Dead kit). The MTS assay was chosen to measure metabolic
activity because AgNPs will not interfere with the assay endpoint as long as the cells are
thoroughly rinsed prior to adding the reagents (personal experience). The Live-Dead kit
uses a fluorescent, membrane permeable, “Live dye” to count the total number of cells
and propidium iodide to identify dead cells. The A549 cells were seeded to 96-well
culture plates at 7.0 x104 cell/cm2 and allowed to recover overnight, resulting in a
confluent cell layer prior to exposure. The medium was then replaced with fresh culture
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medium containing AgNPs at 0 – 20 g/mL (12.5 g/cm2) and then the cells were
cultured for an additional 24 hours. Viability was determined using the Live-Dead kit
according to the manufacturer’s recommendations, and the data was normalized to the
percent of the mean, control viability. The assay was conducted on three different days
with four replicates of each dose. Control viability was greater than 90% in each tests.
For metabolic activity, the exposure medium was removed by aspiration and the cells
were rinsed with 0.3 ml of DPBS. Fresh growth medium was added to each well (0.1 ml)
and then 0.01 ml of MTS reagent was added to each well. The absorbance of MTSformazan at 490 nm was measured immediately, using the Synergy Spectrophotometer,
to represent background absorbance and then the culture plate was incubated for one hour
(37 C, 5% CO2) and the absorbance at 490 nm was measured again. Results were
normalized by the percent of the mean, control absorbance after subtracting background.
The assays was conducted on three different days with 4 replicates for each dose.
Measuring oxidative stress: Redox imbalance was measured by the oxidation of DCFHDA. Cells were seeded to black-walled, 96-well culture plates at 7.0 x104 cell/cm2 and
allowed to recover overnight, resulting in a confluent cell layer prior to exposure. Cells
were exposed to AgNPs (10 g/mL, 6.25 g/cm2) in complete medium for 12, 24, or 48
hours, rinsed with DPBS, and then incubated with 100 M DCFH-DA in phenol free
RPMI 1640 for 1 hour. The fluorescence of the oxidized probe was then measured at the
excitation wavelength of 438 nm and emission of 525 nm (Ex485/Em528), using the
well-scan mode of the Synergy HT Spectrophotometer Cells exposed to H2O2 (50 M)
for 30 minutes were used as positive control to confirm the detection of intracellular
oxidative stress. The relative fluorescence of treated cells was normalized to that of
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untreated control cells and expressed as a multiple of the untreated control cells. The
experiment was conducted on 3 different days with 4 replicates per treatment. In a second
study, the cells were exposed to AgNPs for only 24 hours at a range of concentrations (0,
5, 10, and 20 g/ml) and then they were provided fresh, AgNP-free medium daily for 3
days. Each day, eight wells per dose were analyzed for oxidative stress, but thirty minutes
before adding the DCFH-DA, NAC (5 mM) was added to half of the wells. The second
study was only conducted once with 4 replicates of each exposure.
The uptake and persistence of AgNPs: The uptake and persistence of AgNPs in A549
cells was studied using a CytoViva imaging system (CytoViva, Auburn, AL) that can
image metal nanoparticles by darkfield microscopy with a specialized condenser to
amplify the light diffracted by the particles. The A549 cells were seeded onto an 8chambered microscope slide and exposed to AgNPs (20 g/mL, 12.5 g/cm2) for 2 days,
rinsed with DPBS, and then cultured for 3 days in AgNP-free medium. The cells were
then rinsed with DPBS, fixed with 2% paraformaldehyde, and counterstained with DAPI,
and then examined under the CytoViva Imaging System.
Measuring senescence-associated -galactosidase activity (SA--Gal): SA--Gal was
measured quantitatively using the Senescence Cells Histochemical Staining Kit
(histological stain) and qualitatively using the Quantitative Cellular Senescence Assay
Kit (fluorescent stain). Cells were seeded to 48-well culture plates at 1.6 x104 cell/cm2
and allowed to recover overnight. The seeding density was adjusted from that of the
cytotoxicity and oxidative stress tests to prevent confluence during the 5-day study
(overnight recovery, 24-hour exposure to AgNPs, and 3-day post-exposure incubation)
because preliminary studies revealed that confluent cells had an increase in SA--Gal that
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was not related to AgNP exposure (Figure 5e). The cells were then exposed to AgNPs at
10 g/mL (6.25 g/cm2) in complete culture medium for 24 hours. Immediately
following exposure, cells were rinsed with DPBS and then detached from the culture
surface by incubation with 0.25% trypsin solution at room temperature until lifting of the
cell layer was obvious (typically 10 minutes) and then complete culture medium was
added to neutralize the trypsin. For histochemical staining, the entire volume was
transferred to one well of a 12-well plate and the cells were cultured an additional 3 days
in complete culture medium. For fluorometric staining the cells were counted using a
hemocytometer and seeded to a black-walled, 96-well imaging plate at 1.6 x104 cell/cm2
and then cultured an additional 3 days in fresh, complete medium.
The histochemical stain probes for lysosomal -galactosidase activity at nonoptimal pH which is the hallmark staining method developed by Dimri et. al. (Dimri, et
al., 1995). The manufacturer’s recommendations were followed except staining was
shortened to reduce the background staining (Figure 6d). In brief, cells were partially
fixed by a 6-minute treatment with 2% formaldehyde and 0.2% glutaraldehyde at room
temperature. The cells were rinsed and then stained with a solution containing potassium
ferricyanide, potassium ferrocyanide, and X-gal, for 4 hours at 37C. Three images were
captured from each well using a QColor 3 camera (Olympus America, Melville, NY) and
QCapture Pro 6 software (QImaging, Surrey, BC, Canada). The number of SA--Gal
positive (blue) and negative cells in each image were counted using ImageJ software
(NIH, Bethesda, MD). For a positive control, cells were treated with 50 M H2O2 for 3hours and then subcultured and stained in the same manner as AgNP-exposed cells. Each
exposure was conducted in triplicate and repeated on at least 3 different days.
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The fluorometric stain measured -galactosidase activity in live cells using a
fluorogenic substrate after pre-treating the cells with a lysosomotropic agent in order to
increases lysosomal pH and distinguish SA--Gal from intrinsic -galactosidase activity.
The manufacturer’s recommendations were followed expect for two adjustments: the
pretreatment solution was used at 2-fold greater concentration in order to reduce
background staining, and the cells were fixed with 4% paraformaldehyde after SA--Gal
staining, and then counterstained with Hoechst 33342. Fluorescent images were captured
using a BD Pathway 435 Confocal Microscope (BD, Franklin Lakes, NJ) and evaluated
visually for the presence of SA--Gal positive cells. Doxorubicin (DOX) was used as a
positive control for fluorometric staining because I found it to be more effective than
H2O2 at inducing senescence in A549 cells. The cells for DOX treatment were seeded
directly to a black-walled, 96-well imaging plate, recovered overnight, and then they
were treated with 50 M DOX for 1 hour. Cells were then rinsed with DPBS and cultured
an additional 3 days in fresh, complete culture medium prior to staining. Two studies
using the fluorescent stain were conducted on different days with four replicates of each
treatment.
Measuring proliferation and senescent morphology: Cells were seeded to 48-well
culture plates at 1.6 x104 cell/cm2 and allowed to recover overnight. Cells were exposed
to 10 g/mL AgNPs (6.25 g/cm2) for 24 hours (37 C, 5% CO2) and then rinsed with
DPBS and detached from the culture surface by incubation in 0.25% trypsin solution at
room temperature until lifting of the cell layer was obvious (typically 10 minutes). The
cells were then detached completely by forcefully pipetting the trypsin solution over the
cells. I then counted viable cells using the Countess automated cell counter (Life
22

Technologies, Grand Rapids, NY) and transferred 4.4 x 105 viable cells into a new 100
mm culture dish (8 x103 cells/cm2) with fresh, AgNP-free medium. DOX was used as a
positive control in morphology and proliferation studies because preliminary tests found
it more effective at growth inhibition than H2O2. In order to maintain higher cell numbers
for analysis, the cells treated with DOX (50 M for 1 hour) were not trypsinized but
simply rinsed with DPBS and then remained in the same culture dish with fresh,
complete medium. Proliferation rate was measured by tracking the cumulative population
doubling (CPD) during 20 days of recovery in AgNP-free medium following the method
of Cristofalo, et. al. (Cristofalo, et al., 1998). Briefly, cells were subcultured at 70 – 80%
confluence by detaching them with trypsin, counting them using the Countess, and
transferring 4.4 x 105 viable cells to a new 100 mm culture dish in the same way as
described above at the end of the AgNP exposure. The CPD was then calculated using
equation 1, in which X = the number of population doublings since the last subculture; NH
= the number of cells in the culture at the time it was subcultured; and NI = the initial
number of cells or the number of cells transferred into the culture dish during the last
subculture. The cumulative doubling was calculated by the sum of all X’s from the time
when the exposure to AgNPs ended.
𝑋=

log10 𝑁𝐻 − log10 𝑁𝐼
log10 2

Since the cells were subcultured based on confluence, AgNP-treated and control
cultures were often subcultured on different days. In addition, the culture dishes were
coded to partially blind me to their treatment information, and that sometimes resulted in
replicate cultures being subcultured on different days. In order to compare the CPD
between treatments, all of the replicate CPD results for a particular treatment were pooled
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and the slope of the linear regression of CPD over time was compared by analysis of
covariance. I also examined cells for senescent morphology during the CPD study by
capturing representative, microscopic images of each culture on the 3 day after exposure
ended. I analyzed the images for morphological changes including measuring the surface
area of each cell using ImageJ software. The experiment was conducted on three different
days with three replicate cultures for each exposure group.
Statistical analysis: Statistical analysis was accomplished with a combination of
GraphPad Prism 5 for Windows (GraphPad Software, La Jolla, CA) and the data analysis
tool pack in Microsoft Excel. Studies with more than two variables were compared by
one-way ANOVA and if the difference between means was significant (p ≤ 0.05)
individual means were compared by Dunnett’s Multiple Comparison post-test (p ≤ 0.05).
The distribution of sizes in the surface area of control and AgNP-treated cells was not
normally distributed and so the nonparametric, Mann Whittney test was used to compare
the means (p ≤ 0.05).

Results
Characterization of the AgNPs: The AgNPs were mostly spherical with a mean primary
diameter of 9.1 nm (± 1 nm) (Figure 1 and Table 1). The mean hydrodynamic diameter in
water was 9.8 nm (± 1 nm) and in culture medium was 66.7 nm (± 0.2 nm), indicating that
some agglomeration occurred. The zeta potential was negative 35 mV (± 0.6 mV) in water
and negative 9 mV (± 0.45 mV) in culture medium, suggesting a change in solvation or
interaction with salts or proteins in the culture medium that reduced the relative surface
charge and therefore the electrostatic repulsion between particles, allowing them to
agglomerate. The AgNPs had an absorbance maximum at a wavelength of 389 nm, which
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is typical for 10 nm silver spheres (data not shown). In a separate study of the dissolution
of these same AgNPs, less than 1% of the total silver was released as Ag+ after a 24-hour
incubation in cell-free culture medium (Maurer, et al., 2013).
max
(nm)
389

Zeta potential (mV)
Mean, Primary Hydrodynamic diameter (nm)
Diameter (nm) Z-average in Z-average in
Mean in
Mean in
± SD
water ± SD medium ± SD water ± SD medium ± SD
9.1 ± 1.0
9.8 ± 1.0
66.7 ± 0.2
 35 ± 0.6
 9 ± 0.45
Table 1: Characterization of the citrate-coated AgNPs from
nanoComposix. The wavelength of maximum absorbance (max) was
determined using a plate reader spectrophotometer. The mean, primary
diameter was measured from TEM images using ImageJ software. The
hydrodynamic diameter and zeta potential were determined using the
ZetaSizer Nano. SD is the standard deviation of the mean, nm is
nanometers.
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Figure 1: Representative TEM images of the citrate-coated AgNPs from
nanoComposix. The particles were dried on a Formvar carbon-coated,
copper TEM grid and images were captured using a Hitachi H-7600 TEM
at 200,000x magnification.

Overt toxicity: The MTS and Live-Dead Cell assays indicated no effect on metabolic
activity or viability, respectively, following a 24-hour exposure to AgNPs in the dose
range of 5 – 20 g/ml (Figure 2). Since the AgNPs did not cause an effect after a 24-hour
exposure, the dose range tested would be reported as non-toxic in a typical in vitro,
cytotoxicity study. The concentration of 10 g/ml was chosen for further study because
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that dose would be considered non-toxic based on these results and in a previous test
using the same AgNPs and A549 cells (Maurer et al. 2014).

Figure 2: The AgNPs were not cytotoxic using standard MTS and LiveDead cell assays. Confluent cultures of A549 cells were exposed to AgNPs
for 24 hours at the concentrations indicated on the graph in complete growth
medium. The cells were then rinsed thoroughly to remove residual silver
and then the MTS assay was conducted to measure metabolic activity or
membrane integrity was assessed using the Live-Dead cell assay. The tests
were conducted on three different days with four replicates for each
treatment. There was no significant difference between treatments (p ≤
0.05), measured by one way ANOVA.

Oxidative stress: The AgNPs caused oxidative stress in A549 cells after 48-hours of
continuous exposure (Figure 3a). There was no oxidative stress detected after 12 or 24
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hours of exposure, and therefore the AgNP-induced oxidative stress did not become
apparent until after an exposure that was longer than the typical, in vitro cytotoxicity
study, and at a concentration that did not cause overt cytotoxicity. The AgNPs also
caused oxidative stress after the direct exposure to AgNPs had ended (Figure 3b). At zero
hours of recovery (equivalent to the 24 hour time point in Figure 3a) there was no
apparent oxidative stress, but after 24 hours of recovery (48 hours after the start of
exposure), and 48 and 72 hours of recovery, there was a concentration-dependent
increase in stress that was mitigated somewhat by the addition of NAC. The change in
oxidative stress between days for each exposure was also statistically significant. The
results confirm that even after the AgNPs are removed from the culture medium,
oxidative stress continued to increase, suggesting that the AgNPs persist inside the cells
and continue to perturb redox homeostasis. Alternatively, the AgNPs could cause
irreparable damage to the cells so that their health degrades over time and it became
apparent in the redox imbalance measured here.

Figure 3: Oxidative stress was apparent in A549 cells 48 hours after the start
of AgNP exposure. (a) A549 cells were exposed continuously to 10 g/ml
AgNPs for 12, 24, or 48 hours and oxidative stress was measured using
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DCFH-DA. Stress was only detected after 48 hours. (b) A549 cells were
exposed to 0, 5, 10, or 20 g/ml AgNPs for 24 hours and then while the
cells recovered in silver-free medium, the development of oxidative stress
was monitored daily using DCFH-DA. Stress was detected after 24 hours
of recovery (48 hours after the start of exposure) at each concentration of
AgNPs. During recovery (b), half of the wells were treated with NAC (5
mM) in order to confirm that the increased fluorescence was due to
oxidative imbalance. The results were analyzed by one way ANOVA with
a Dunnett’s Multiple Comparison post-test (p ≤ 0.05). An asterisk (*)
denotes statistically significant difference from untreated control cells (a
and b) and between each dose group (b). The white dot indicates where the
addition of NAC caused a significant change (p ≤ 0.05) in fluorescence from
the similar sample without NAC.

Uptake and persistence of AgNPs: The A549 cells were exposed to AgNPs, rinsed to
remove extracellular nanoparticles, cultured an additional 3 days in medium without
AgNPs, rinsed again, fixed with paraformaldehyde and stained with DAPI. Imaging with
the CytoViva Imaging System revealed that even after the series of rinses and culturing in
AgNP-free medium, the AgNPs were still associated with the A549 cells (Figure 4). The
CytoViva system cannot distinguish between external and internal AgNPs, and so while
the particles are most likely inside the cells due to their persistence after extensive
rinsing, strong attachment to the external cell membrane cannot be ruled out. Likewise,
the CytoViva system cannot positively identify the highly reflective particles as silver,
but nothing else in the culture is expected to produce such an intense signal.
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Figure 4: A representative CytoViva image showing the persistence of
AgNPs. The cells were exposed to AgNPs (20 g/ml) for 24 hours and then
rinsed to remove residual particles and allowed to recover for 3 days in
AgNP-free medium. The cells were then rinsed again, fixed with
paraformaldehyde, stained with DAPI (blue) and then the cells and the
AgNPs (white) imaged using a CytoViva imaging system.
Measurement of SA--Gal: The A549 cells that were exposed to AgNPs at 10 g/ml for
24 hours or to H2O2 (50 M for 3 hours had a statistically significant increase in SA-Gal compared to the untreated controls (Figure 5). The cells had an intrinsically high SA-Gal in preliminary studies (Figure 5d), but once the conditions were optimized by
preventing confluence and reducing the incubation time for staining, background SA-Gal was reduced to about 20% (Figure 5a). Interestingly, the cell density was also
decreased in the cultures exposed to AgNPs (Figure 5b) or H2O2 (Figure 5c) compared to
control which suggests less proliferation in the treated cultures. The cells were partially
fixed and stained in a buffer at pH = 6.0, so the detachment of unhealthy cells in the
treated cultures during staining cannot be ruled out.
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The conditions for using the fluorescent stain also had to be optimized. Prior to
optimization, most of the untreated cells stained positive for SA--Gal (Figure 6d), but
under optimal conditions, little stain was found in untreated control cells (Figure 6a) but
many A549 cells that were exposed to AgNPs were positive for the SA--Gal marker
(Figure 6b) and virtually all of those treated with the positive control, DOX, stained
positive (Figure 6c).
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Figure 5: Histochemical staining revealed increased SA--Gal in A549 cells.
The A549 cells were untreated (a and d) or exposed to 10 g/ml AgNPs for 24
hours (b) or to the positive control, 50 M H2O2 for 3 hours (d) and then
detached using trypsin and transferred to a larger culture dish. After 3 days of
culture in silver-free growth medium, the cells were stained for SA--Gal using
the Senescence Cells Histochemical Staining Kit. Digital images were captured
the number of SA--Gal positive (blue in a – d) or negative cells could be
counted. There was a high level of intrinsic SA--Gal (d), and so the culture
and staining conditions had to be optimized in order to reduce the background
staining. The experiment was conducted on 3 different days with 3 replicate
treatments each day and the difference in the number of positive cells between
treatments was compared by one-way ANOVA with a Dunnett’s Multiple
Comparison post-test (p ≤ 0.05). The results are graphed as the fold-difference
in positive cells from the untreated control and the asterisk (*) denotes
significant difference from the untreated control cells.
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Figure 6: Increased SA--Gal in A549 cells was confirmed by fluorescence
staining. The A549 cells were either untreated (a and d) or exposed to 10
g/ml AgNPs for 24 hours (b) or to the positive control, 50 M doxorubicin
for 1 hour (c) and then transferred to a 96-well culture dish and cultured for
an additional 3 days in silver-free medium. The cells were then stained using
the Quantitative Cellular Senescence Assay Kit which stained senescent
cells with a fluorescent dye (yellow in b – d). The cells were then fixed with
paraformaldehyde and counterstained with DAPI (blue in a – d) prior to
collecting fluorescent images using a BD Pathway 435 Confocal
Microscope. The images were evaluating for visual confirmation that more
cells stained positive for SA--Gal after treatment with AgNP or Dox.
Intrinsic staining was high (d) and so conditions were optimized to reduce
the background staining.
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Senescent morphology: Senescent cells adopt a large, flat morphology due to continued
growth and protein synthesis in the absence of cytokinesis, which is termed hypertrophy
(Chen & Ames 1994; Matsumura et al. 1979). In this study, hypertrophic A549 cells were
readily identifiable by their large surface area and the thin, flat appearance of their
cytoplasm (Figure 7, arrows). Some hypertrophic cells appeared in the untreated control
cultures (Figure 7a, arrow), but they were uncommon. Hypertrophic cells were more
common in cultures exposed to AgNPs (Figure 7b, arrows) and very common after
exposure to the positive control, DOX (Figure 7c, arrows). Under greater magnification
(Figure 8) the elongated morphology that was frequently observed in hypertrophic cells is
readily apparent (arrows). Interestingly, there were some cells noted in the SA--Gal,
histochemical-stain study that were exceptionally hypertrophic (surface area >20,000
m2), positive for SA--Gal, and multinucleate (Figure 9).
The surface area of A549 cells is highly variable (Table 2). The surface area of
each cell was measured from the images captured during the proliferation assay by using
ImageJ software, calibrated to a scaled microscope slide. Untreated cells ranged in size
from 49 – 3,030 m2 with a median of 236 nm and mean of 275 nm (± 210). Cells treated
with AgNPs ranged in size from 40 – 5,113 m2 plus one very large cell at 348,654 m2
which was 38-fold larger than the next largest cell. The median and mean size of the
AgNP-treated cells without the very large cell was 241 nm and 327 nm (± 372),
respectively. When the largest cell was included the mean was 629 nm (± 10,252) but the
median was unchanged. The cell-size distribution was greatly skewed from a normal
distribution (Figure 10) and so the non-parametric, Mann Whitney test was used for
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statistical comparison, but the p valued (0.076) did not meet the criteria for significance
(p ≤ 0.05).

Number
Surface area (m2)
Treatment of cells
measured Mean ± SD Median (range)
Untreated
AgNP

1185
1155

275 ± 210
327 ± 372

Cells with surface area greater
than the median control by:
2-fold

3-fold

4-fold

236 (49 – 3,030) 86 (7%) 26 (2%) 18 (2%)
241 (40 – 5113) 154 (13%) 68 (6%) 46 (4%)

Table 2: The occurrence of hypertrophic cells in A549 cell cultures
exposed to AgNPs. The cells were untreated or exposed to 10 g/ml
AgNPs for 24 hours and then rinsed, detached from the culture plate using
trypsin, and transferred to a new culture plate with AgNP-free medium.
After 3 days, microscopic images were captured and the surface area of
A549 cells was measured using ImageJ software. SD is the standard
deviation of the mean. The means were compared by the non-parametric,
Mann Whitney test and were not found to have a p-value of 0.076.
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Figure 7: Representative images of A549 cells displaying senescent,
hypertrophic morphology. The cells were untreated (a) or exposed to 10 g/ml
AgNPs for 24 hours (b) or to 50 mM doxorubicin for 1 hour (c), and then
rinsed, detached using trypsin, and transferred to a new culture plate with
AgNP-free medium. Hypertrophic cells were clearly visible (arrows) after
three days.

Figure 8: Images of untreated and AgNP-treated A549 cells under greater
magnification. The cells were untreated (a) or exposed to 10 g/ml AgNPs for
24 hours (b) and then rinsed, detached from the culture plate using trypsin, and
transferred to a new culture plate with AgNP-free medium. After 3 days,
microscopic images were captured. Two hypertrophic cells are clearly visible
(arrows) in the AgNP-treated culture.
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Figure 9: Two examples of exceptionally large hypertrophic cells. The
image was from the histochemical-staining study in which A549 cells were
exposed to AgNPs (10 g/ml) for 24 hours, allowed to recover for 3 days
in AgNP-free medium, and then stained for SA--Gal. The blue, SA--Gal
stain is readily visible around the multiple nuclei-like structures and the
rough edge of the plasma membrane is highlighted by red arrows for one
cell and green arrows for the other cell. The cells had surface areas greater
than 20,000 m2.
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Figure 10: The distribution of cell sizes for untreated and AgNP-treated
A549 cells. The cells were untreated (red) or exposed to 10 g/ml AgNPs
(green) for 24 hours, rinsed, and transferred to a new culture plate with
AgNP-free medium. After 3 days, microscopic images were captured and
the surface area of each cell was measured using ImageJ software. The inset
is zoomed in on the same data for cell sizes greater than 800 m2.
Proliferation: Senescent cells will not proliferate, even resisting mitogenic stimulation
(Chen & Ames 1994). In this study, proliferation was assessed by calculating the
cumulative population doubling (CPD) during 20 days of recovery from AgNP exposure
(10 g/mL) or treatment with DOX (50 M for 1 hour). The cell population treated with
DOX failed to double during the 20 days of recovery (data not shown). Cells exposed to
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AgNPs for 24-hours had a small but statistically significant (p ≤ 0.05) decrease in the rate
of population doubling when compared to untreated cells (Figure 11).

Figure 11: The proliferation of A549 cells was reduced after exposure to
AgNPs. The cells were untreated (●) or exposed to 10 g/mL AgNPs (▲)
for 24 hours and then immediately transferred to a new culture dish for
recovery in silver-free medium. The cells were subsequently transferred to a
new dish each time the culture reached about 70% confluence. During the
transfer, cells were detached using trypsin, counted using Trypan blue dye
and a Countess automated cell counter and then 4.4 x 10 5 viable cells (8000
cells/cm2) were transferred to the new culture dish. The number of times that
the cell population doubled was calculated after each transfer using Equation
1 in Materials and Methods. The data was analyzed by linear regression of
the CPD against the recovery day. The coefficient of determination (R2) for
each treatment was 0.99 and the slopes of the two lines were significantly
different (p < 0.0001) by analysis of co-variance.
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Discussion
The expanding use of AgNPs, especially in wound management, and their
persistence in tissues raises concern over their potential to cause long-term effects that
are not apparent in typical, in vitro toxicity tests. This study found that AgNPs can cause
changes in redox homeostasis even 3 days after direct exposure has ended. I also
investigated one consequence of potential long-term oxidative stress: premature cellular
senescence. I found that AgNPs were able to induce signs of premature cellular
senescence after an exposure (24 hours at 10 g/mL, 6.25 g/cm2) that did not cause
overt signs of toxicity but did cause redox imbalance after 2 days, even if the exposure
ended after the first day. Senescence was marked by an increase in SA--Gal, a hallmark
of senescent cells (Dimri et al. 1995). The increase in this study was about 2-fold over
unexposed cells after the assay conditions were optimized to overcome a high
background SA--Gal in the A549 model used here. High background SA--Gal has also
been reported in transformed and quiescent cells (Severino et al. 2000), and its utility as a
biomarker for senescence has been called to question, mainly because it appears to be
greater in all non-dividing cell (Cristofalo 2005; Yang & Hu 2005). The increased
enzymatic activity associated with SA--Gal is apparently caused by an increase in the
concentration of lysosomal -galactosidase which may result from increased expression
or simply from the longer residence of lysosomes in cells that are not dividing to dilute
their lysosomal content between daughter cells (Kurz et al. 2000; Lee et al. 2006). It is,
therefore, important to analyze additional endpoints to confirm the induction of
senescence. In this study, I also studied cellular morphology and proliferation to
determine if cellular senescence was induced.
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I saw an increase in hypertrophic cells associated with AgNP exposure. In
addition to a statistically significant increase in surface area and the more frequent
observation of large flat cells in AgNP-treated cultures, some exceptionally enlarged cells
were also observed which were also multinucleate. Cells with more than one nuclear
body were also observed in less dramatically enlarged cells which were treated with
AgNPs. Multinucleation is not considered a biomarker for senescence, but is often
reported in senescent cells including serially passaged fibroblasts (Matsumura et al.
1979), 5-Bromo-2-deoxyuridine-treated A549 cells (Masterson & O’Dea 2007), and
DOX-treated A549 and colon cancer cells (Litwiniec et al. 2010; Sliwinska et al. 2009).
Although I did not observe multinucleated cells after DOX treatment, my observations
were conducted 3 days after treatment when the number of cells had already decreased by
about half, and the multinucleate cells may have been lost during that time. In line with
that theory, Litwiniec, et. al. (Litwiniec et al. 2010), observed multinucleated A549 cells
just one day after treatment and Sliwinska, et. al. (Sliwinska et al. 2009), reported a
dramatic decrease in multinucleated colon cancer cells between days 1 and 7 posttreatment. The more favorable survival of AgNP-induced multinuceated cells over DOXinduced, may be related to their potency. Both have been linked to DNA damage
including double-stranded DNA breaks (Ahamed et al. 2008; Binaschi et al. 1997);
however, as I demonstrated in this work, DOX is very potent and acts rapidly while
AgNPs require high concentrations and/or long exposures to induce cytotoxic effects.
The induction of cellular senescence results in an enlarged and flattened cellular
appearance which has been linked to disruption of the actin cytoskeleton (Alexander et al.
2004; Kwak et al. 2004; Lim et al. 2000). Cytoskeletal changes were not studied in this
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work, but another study conducted in the same laboratory, and simultaneous with mine,
found that long-term exposure to AgNPs at much lower concentrations than I used here
(4 pg/mL daily for 14 weeks) can disrupt the actin cytoskeleton in HaCaT keratinocytes
(Comfort et al. 2014). Comfort, et. al., did not study senescence in their work, and they
exposed their cells continuously instead of allowing recovery like I did, but they
demonstrated that AgNPs can cause a chronic state of cellular stress, further enforcing the
potential for AgNPs to induce chronic redox imbalance that could lead to cellular
senescence.
Senescent cells undergo permanent cell cycle arrest but in this study, AgNPs had
only a moderate effect on proliferation. A549 cells double about every 22 hours, so rapid
growth of unaffected cells might mask the effect of senescence. The relative percent of
senescent cells would be further reduced during each subculturing event as only a portion
of senescent cells were transferred to the new culture dish and would be further diluted
by non-senescent, dividing cells. Furthermore, large, flat, senescent cells do not detach
from the culture surface as readily as normal cells (Walen 2006) increasing the possibility
that fewer senescent cells were transferred during each subsequent subculturing event.
Longer exposures or a higher concentration of AgNPs might increase the number of
affected cells and more clearly demonstrate the induction of senescence; however, our
goal here was to determine if an exposure that appeared to be non-toxic in typical in vitro
tests might induce senescence, and so future studies will have to investigate diferent
exposure regimens. In this study, oxidative stress became apparent 48-hours after AgNPexposure, and so in order to determine if a longer exposure would have a greater effect on
proliferation, I tracked the CPD of A549 cells for several days after a 2- or 3-day
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exposures to AgNPs, but saw no difference in the outcome from the 24-hour exposure
(data not shown). I chose not to test higher concentrations because other studies with
similar AgNPs have demonstrated cytotoxicity at 20 g/mL or greater in various cell
lines (Braydich-Stolle et al. 2005; Carlson et al. 2008; Comfort et al. 2011; Gliga et al.
2014), and in this study, the oxidative stress induced by 20 g/ml AgNPs was
dramatically increased over the 10 g/ml at 3 and 4 days after exposure. Although that
dramatic increase in oxidative stress may correlate with a greater number of senescent
cells, I felt that the 10 g/ml exposure was already greater than biologically relevant
concentrations, and so increasing the concentration would only artificially inflate the
hazards associated with AgNP-exposure. Using Acticoat as an example, the dressing is
reported to release about 3.7 g of silver per cm2 of dressing (Wright et al. 2002). The
dose I used in this study may already exceed that amount: assuming that all of the AgNPs
that were added to the culture medium deposited onto the culture surface, the 10 g/ml
dose would result in 6.25 g of silver per cm2 of culture surface, almost twice the
concentration that Acticoat is expected to release, and Acticoat dressing has the highest
concentration of silver among silver-containing dressings (Boonkaew, Kempf, Kimble &
Cuttle 2014).
Others researchers have also reported an apparent state of senescence without
causing permanent growth arrest. A549 cells exposed to pyocyanin (Muller 2006) or
particulate pollutants (Sanchez-Perez et al. 2014) displayed a senescent morphology and
increased SA--Gal, but pyocyanin only decreased proliferation temporarily and
particulate pollutants had no effect on proliferation. The limited effect on proliferation in
A549 cells reported here and by others is most likely the result of a gene deletion which
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prevents A549 cells from expressing the p16INK4A protein (Okamoto et al. 1995).
Senescence is typically brought about by a sequential induction of p53, p21CIP1, and
p16INK4A proteins (Alcorta et al. 1996). The tumor suppressor protein, p53, initiates cellcycle arrest in response to DNA damage. If DNA is not repaired, p53 can induce
apoptosis, but the cyclin-dependent kinase inhibitor (CDKi), p21CIP1, maintains cell cycle
arrest and inhibits p53-induced apoptosis. In senescence, p21CIP1 is replaced by p16INK4A
which is also a CDKi but it permanently stops the cell cycle and inhibits apoptosis.
Another CDKi, p27Kip1 can cause senescent-like growth arrest (Collado et al. 2000) and
its level was reported to increase in senescent, 5-Bromo-2-deoxyuridine-treated, A549
cells (Masterson & O’Dea 2007). Interestingly, p27Kip1 is less robust at arresting the cell
cycle than p16INK4A (Pajalunga et al. 2007). In this study, AgNPs had a modest effect on
the proliferation of the p16INK4A deficient A549 cells. If the senescent phenotype induced
by AgNPs in this study (or pyocyanin or particulate pollutants in the other studies) was
mediated by p27Kip1 then the A549 cells may have evaded permanent cell cycle arrest by
overcoming that less robust pathway, but that remains to be tested. I confirmed the lack
of p16INK4A protein in the A549 cells used in this study by staining untreated, AgNPtreated, and H2O2-treated cells with a human p16INK4A protein (Abcam) and Alexa Fluorlabeled secondary antibodies (Invitrogen) and visualizing the cells using fluorescence
microscopy (data not shown). Although there was no fluorescent signal corresponding to
the p16INK4A antibody, I did not employ a positive control to verify that the antibody
could detect the intracellular protein, and so those results were inconclusive. Future
studies should compare the expression of p53, p21CIP1, p16INK4A, and p27Kip1 by
measuring gene transcripts and protein products in order to determine if the relevant
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proteins are induced, if p16INK4A is actually missing from the A549 cells, and if p27Kip1
might be induced in place of the p16INK4A protein.
The effect of AgNPs on proliferation might also be studied by using the Click-iT
EdU Assay for Flow Cytometry (ThermoFisher Scientific) which measures the
incorporation of 5-ethynyl-2′-deoxyuridine (EdU) during DNA synthesis, using click
chemistry to bind a dye-labeled azide to the EdU. Since the cells are not disrupted, flow
cytometry can be used to measure dye incorporation in all of the cells, and changes in
side scatter can also be used to detect particles present in the cytoplasm (Greulich et al.
2011). The presence of AgNPs could then be correlate with reduced DNA synthesis and
indicate whether or not cells with intracellular AgNPs are proliferating.
Additional studies using a human, primary cell model are also necessary to further
characterize the potential for AgNPs to induce cellular senescence in a normal human
cell. Primary cells are not resistant to senescence and would be a more accurate
representative for in vivo exposure. Alternatively, an animal model of wound healing
could be employed. The results of this study, however, should bring attention to the
potential for AgNPs to cause long-term effects which are not readily apparent in the
typical, short-term, in vitro cytotoxicity test.
Another potential explanation for the increased size and reduced proliferation of
A549 cells is their differentiation from alveolar type II pneumocyte (AT1)-like cells to
alveolar type I pneumocyte (AT2)-like cells. The AT1 cells are smaller, cuboidal
epithelial cells, while the AT1 cells are squamous epithelial cells with a more circular
shape and larger surface area (Cheek et al. 1989; Ehrhardt et al. 2008). Primary, AT2
cells will differentiate into AT1 cells after several days in culture (Cheek et al. 1989;
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Fuchs et al. 2003), but A549 cells do not spontaneously differentiate in culture (Foster et
al. 1998), and must be treated with dexamethasone in order to induce differentiation
(Barar et al. 2007). If AgNPs induce the differentiation of A549 cells into AT1-like cells
then that would also cause an increase in surface area and decrease in proliferation
similar to what was observed in this study. I attempted to distinguish the induction of
senescence from differentiation by staining untreated, AgNP-treated, and dexamethasonetreated A549 cells with tannic acid and osmium tetroxide which has been described by
others for staining the surfactant-storing lamellar bodies that are present in AT2 but not
AT1 cells (Foster et al. 1998; Kalina & Pease 1977; Mason et al. 1985); however, there
was no apparent staining in any of the cultures (data not shown), rendering the test
inconclusive. Future studies should evaluate the presence of lamellar bodies and
surfactant proteins in enlarged cells to confirm that they are senescent AT2 cells.
Alternatively, the presence of caveolae along with the absence of lamellar bodies would
reveal that differentiation to AT1 cells is responsible for the change in cellular
morphology.
In relation to wound management, the impact of cellular senescence on the repair
and long-term health of tissues is not well understood. Demaria, et. al. (Demaria et al.
2014) claim that senescence has a vital role in wound closure. They used a p16INK4A
reporter construct to show that senescent cells were transiently present in the wound and
suggest that because senescent cells secrete platelet derived growth factor (PDGF), which
has an important role in wound closure, that the senescent cells were essential. The
researchers did not determine if the expression of p16INK4A was actually linked to the
induction of senescence. There is, in fact, a complicated interplay between transforming
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growth factor beta (TGF) and PDGF at the site of the wound (Fischer et al. 2007;
Pierce, Mustoe, Lingelbach, Masakowski, Griffin, et al. 1989; Pierce, Mustoe,
Lingelbach, Masakowski, Gramates, et al. 1989). In addition, TGF has been shown to
upregulate p16INK4A (Vijayachandra et al. 2009). It is not clear if TGF-induced
expression of p16INK4A actually induces senescence, or if senescence-induced expression
of p16INK4A would have the same effect on wound resolution as that induced by TGF.
The research by Demaria, et. al., did show that wounds healed slower in p16/p21
knockout mice than in normal mice, suggesting that p16 INK4A expression is important in
wound resolution, but its role is unknown. Demaria, et. al., also found that
myofibroblasts, which secrete collagen during wound healing, were the most likely
source of the increased p16INK4A expression, but myofibroblasts have been shown to
undergo apoptotic death at the end of the granulation stage of wound closure
(Desmouliere et al. 1995). Since p16INK4A inhibits apoptosis, inducing senescence in
those cells may lead to excessive collagen deposition. Senescence is also associated with
intrinsic expression of inflammatory factors. In general, inflammation is good for
preventing bacterial invasion of a wound, but inhibit the other processes in wound
recovery. Alternatively, if the senescence-like phenotype that I observed in A549 cells is
actually differentiation, and AgNPs are also able to induce differentiation in
myofibroblast cells, then the AgNPs might reduce inflammation and hasten wound
healing. They might also cause premature differentiation of the myofibroblasts, thereby
reducing collagen deposition and delaying wound closure. Further tests should be
conducted to determine the effect of AgNP exposure on myofibroblast cells both in vitro,
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to determine if cells differentiate or become senescent, and in an in vivo wound model, to
determine if exposure to AgNPs will hasten or inhibit wound healing.
In summary, it seems clear from my work that AgNPs have the potential to induce
a senescent-like phenotype. Additional studies are necessary, though, to determine if
AgNPs can induce senescence in the cells that are directly associated with wounded
tissues and to evaluate how senescent cells will affect wound resolution.

Conclusion for section 1
This study demonstrated that AgNPs can have a long-lasting effect on mammalian
cells. The AgNPs were persistent in the cell culture and induced oxidative stress which
was not immediately apparent, but increases over time. The senescent-like phenotype
induced in A549 cells after exposure to AgNPs suggests that the long-term effects of
AgNP exposure may be significant; however, additional studies using animal models or
primary cells are necessary in order to support such a conclusion.
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SECTION 2: LOW POTENTIAL FOR BACTERIA TO
DEVELOP RESISTANCE TO SILVER NANOPARTICLES
Summary:
There is a low potential for bacteria to develop resistance to AgNPs but they are not
a silver bullet
The antibacterial properties of AgNPs are well known. Owing to their proven
effectiveness against antibiotic resistant organisms and their continuous, long-term
release of Ag+, some have proposed that AgNPs have a low potential for resistance
development. On the other hand, the slow release of Ag+ might expose bacteria to subinhibitory concentrations, allowing them to adapt and develop resistance. This study
demonstrates that prolonged exposure to ineffective concentrations of AgNPs leads to
resistance in only one of the three bacteria tested, Pseudomonas aeruginosa. The
mechanism of resistance is not yet clear but appears to derive from the phenazine
pigments commonly secreted by that organism.

Material and methods
Chemicals and reagents: The trace-metal grade HCl was from Fisher Scientific;
Analytical solutions for mass spectrometry were from Perkin Elmer; Dulbecco’s
phosphate buffered saline (DPBS) was from Hyclone; acridine orange and Hoechst
33342 were from Invitrogen; and the remaining chemicals were from Sigma. The water
was deionized and filtered by an ELGA system and sterilized in an autoclave (diH2O).
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Synthesis and characterization of AgNPs: Citrate-stabilized AgNPs with a nominal
diameter of 10 nm were synthesized by a standard, one-pot method. Solutions of diH2O,
0.4% (w/v) AgNO3, 1% (w/v) tri-sodium citrate, and 0.5% (w/v) sodium borohydride
were stored at 4 C in order to ensure that a low temperature was maintained during
synthesis. The diH2O was stirred using a magnetic stir bar and then AgNO3 was added to
a final concentration of 0.01% (w/v) followed by sodium borohydride (0.005%) and trisodium citrate (0.004%) at one minute intervals. Immediately following synthesis the
absorbance spectrum of the solution was measured using a Synergy HT
Spectrophotometer Plate Reader (BioTec) and batches with a symmetrical absorbance
peak centered near the 390 nm wavelength were chosen for further characterization and
used in bacterial studies. The 10 nm diameter was chosen because it has been
demonstrated that smaller AgNPs (5 - 15 nm) release more Ag+ (Liu et al. 2010; Zhang et
al. 2011) and are more effective at inhibiting bacteria (Choi & Hu 2008; Samberg et al.
2011) than larger AgNPs. The citrate coating was chosen because a simple, reproducible
synthesis method has been established and the citrate coating provides electrostatic
stability in solution and is not expected to affect bacterial growth. The concentration of
the AgNPs was determined by dissolving the nanoparticles in 1:3 nitrohydrochloric acid
and quantifying the Ag+ using inductively coupled plasma mass spectrometry (ICP-MS)
with a NexION 300D instrument (Perkin-Elmer). When necessary, the stock solutions
were concentrated by using tangential flow filtration (TFF) with a MicroKros 10-kD, 20
cm2 filter (Spectrum Labs) on a KrosFlo Research IIi TFF system (Spectrum Labs). The
concentration of Ag+ in the stock solutions was determined by ICP-MS using the TFF
filtrate. The primary size of AgNPs was determined by transmission electron microscopy
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(TEM). An aliquot of the AgNP solution (8 l) was transferred to a Formvar carboncoated, copper TEM grid (Electron Microscopy Sciences) and allowed to air-dry. Images
were captured using a Hitachi H-7600 electron microscope, and the particle diameters
were measured using ImageJ software (NIH) which was calibrated to the scale bar that
was generated by the microscope. In order to measure the primary size of AgNPs, the
particles were dispersed in water and dried on TEM grids. The size of agglomerates were
measured by dispersing the particles in MHB2 and then drying them on TEM grids. The
diameter of each agglomerate was calculated as the mean of five measurements: the
vertical and horizontal lengths through the approximate center of the agglomerate and the
lengths from the upper most left to lower most right, and upper most right to the lower
most left points. The hydrodynamic diameter and zeta potential of the AgNPs were
determined by dynamic light scattering and laser Doppler micro-electrophoresis using a
ZetaSizer Nano (Malvern Instruments) and solutions of AgNPs which were diluted to 25
g/ml in the appropriate media (water or broth).
Organisms and culture conditions: The test organisms were purchased from ATCC and
included Pseudomonas aeruginosa (ATCC 27853), Acinetobacter baumannii
(ATCC19606), and Staphylococcus aureus (ATCC 29213). Each is an opportunistic
pathogen known to interfere with wound healing, especially burns (Church et al. 2006)
and wounds from military conflicts in the Middle East (Maragakis & Perl 2008; O’Shea
2012). In addition, each of the organisms is known for their potential to develop
resistance to various antibiotics (Hancock & Speert 2000; Maragakis & Perl 2008;
Rossolini et al. 2014). The stock cultures of each organism were stored at -80 C in
Mueller Hinton Broth 2 (MHB2) supplemented with 10% (v/v) glycerol. Frozen stocks
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were prepared for experiments by steaking them on Mueller Hinton agar (agar) which
made by adding agarose (2% w/v) to the MHB2 medium prior to sterilization. After
culturing overnight at 37 C, representative colonies were transferred to MHB2 and
cultured an additional six hours to achieve exponential growth and a sufficient density to
conduct experiments.
Antibacterial efficacy: the MIC and MBC: I measured antibacterial efficacy by
determining the minimum inhibitory concentration (MIC) and minimum bactericidal
concentration (MBC) using a standard, microtiter method modified slightly from those
described by Amsterdam and by Jeannot and Plesiat (Amsterdam 1996; Jeannot & Plesiat
2014). The agents to be tested were prepared in flat-bottom, 96-well culture plates by
serial, 2-fold dilution in diH2O, leaving 50 l in each well. The bacterial inoculum was
prepared by diluting a culture in the exponential growth phase (after 6-hours at 37 C) to
an optical density at 600 nm of 0.10 (OD600 = 0.10) using pre-warmed MHB2, which was
previously found to correlate with a bacterial density of about 1 x 108 colony forming
units (CFU)/ml. The culture was then diluted 1:1000 in pre-warmed MHB2 to make an
inoculum density of about 1 x 105 CFU/ml. The inoculum was then added to the test
wells (50 l). I confirmed the bacterial density in the inoculum by dilution-plate
counting. The test plate was then incubated at 37 C for 18 to 20 hours and then
evaluated for bacterial growth based on turbidity. The MIC was defined as the lowest
concentration with no visible turbidity. I determined the MBC by spotting 10 l from the
MIC well and each of the next three greater concentrations onto agar and incubating the
agar plate, inverted, at 37 C for at least 18 hours. The concentration which caused a 3log or greater reduction in bacterial density from the inoculum was defined as the MBC,
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and I identified it by the spot with no more than one colony growing. I tested each agent
on at least 4 different days with four replicates on each day. The benchmark agents,
ciprofloxacin (Cipro) and benzalkonium chloride (BZC), were prepared by dissolving the
agents in diH2O at 50 and 500 g/ml, respectively. It was necessary to adjust the pH of
the diH2O to 5.0 using HCl in order to dissolve the Cipro, but I found that the pH was 7.0
once the Cipro was diluted in normal diH2O and mixed with MHB2 for the bacterial
studies. The MIC and MBC of Ag+ were determined using AgNO3 dissolved in diH2O.
Resistance development: The potential for P. aeruginosa, S. aureus, and A. baumannii
to develop resistance to AgNPs, AgNO3, BZC, and Cipro was tested by a broth, stepwiseincreasing exposure model which was adapted from the one described by Entenza, et. al.
(Entenza et al. 1997). I prepared the initial bacterial inoculum at about 1 x 105 CFU/ml in
the same way as described for the MIC study. The test agents were prepared in water at
twice the target concentrations which were 0.25-, 0.5-, 1.0-, 1.25-, and 1.5-fold multiples
of the agent-specific MIC. Equal volumes (1 ml) of the inoculum and the test agent were
then mixed in the wells of a 12-well culture plate and incubated for at least 22 hours at
37 C on a slow-speed, rotary shaker. The greatest concentration in which turbid growth
occurred was labeled the tolerable concentration, and that culture became the inoculum
for the next step by adjusting the OD600 to 0.10 and further diluting the culture 1:1000 in
fresh, pre-warmed MHB2. In this way, the inoculum was the same for each step of the
test (approximately 1 x 105 CFU/ml) in order to avoid falsely identifying resistance due
to a high inoculum being able to overcome the antibacterial agent. In preliminary studies
I found that the MIC of AgNPs did not change when the inoculum was up to one log
greater or less than 1 x 105 CFU/ml. I also found that using 0.25-, 0.5-, 1.0-, 1.25-, and
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1.5-fold multiples of the MIC prevented over-growth of a culture if the inoculum was too
large and loss of cultures if the inoculum was too small, as long as the inoculum was
correct at the next serial transfer. I verified the bacterial density, therefore, in each
inoculum by dilution plate counting and discontinued any experiment which had two
consecutive inoculums greater than 1 x 106 CFU/ml or less than 1 x 104
CFU/ml. The agents were prepared in the same manner for each step, but at multiples of
the tolerable concentration instead of the MIC. This procedure was carried out daily for
up to nine days. Resistance was indicated by a tolerated concentration that was at least 4fold greater than the original MIC. Each species of bacteria was tested at least three times
on different days against each test agent. Resistant cultures were expanded by culturing
them in 50 mL of fresh MHB2, collected by centrifugation at 5,000x relative centrifugal
force (rcf) for 10 minutes, re-dispersed in MHB2 which was supplemented with 10%
(v/v) glycerol, and frozen at -80 C in aliquots of 400 l. The AgNP-resistant bacteria
were tested for cross-resistance to Cipro, BZC, and AgNO3 and the stability of the AgNPresistance was determined by conducting MIC and MBC tests on cultures derived from at
least three different frozen aliquots. I then tested the stability of the resistance to AgNPs
by MIC and MBC testing after serial passage of 10 l of bacterial culture to 4 ml of fresh
MHB2, daily for 9 days.
Resistance mechanisms:
The efflux of fluorescent dyes: I examined differences in general efflux between the
normal P. aeruginosa and the AgNP-resistant strains by using a broth-culture adaptation
of the maximum extrudable concentration assay which was originally described by
Richmond, et. al. (Richmond et al. 2013). In Richmond’s assay, the maximum extrudable
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concentration was that which caused a visible increase in the fluorescence of bacteria that
were growing on agar which was supplemented with ethidium bromide or acridine
orange. I conducted a broth-culture version of the experiment in the same way as the MIC
test, but I replaced the antibacterial agents with the fluorescent dyes Hoechst 33342,
ethidium bromide, and acridine orange, each at a starting concentration of 5 g/ml. The
microtiter test plate was a black-walled, 96-well culture plate and the fluorescent
endpoints were measure using a SpectraMax M2 Multimode Plate Reader (Molecular
Devices) after one hour of incubation at 37 C to allow efflux or at 4 C to inhibit efflux.
The fluorescent endpoints were measured by the following excitation and emission
wavelengths (Ex/Em): Ex502/Em 525 for acridine orange; Ex285/Em605 for ethidium
bromide; and Ex361/Em497 for Hoechst 33342. I used four replicates for each
concentration and tested each dye one time against the normal strain and 715npRPs
strain. In a second test, the efflux of Hoechst 33342 was studied after 10 minutes of
incubation using concentration up to 125 g/ml in the normal strain of P. aeruginosa and
up to 150 g/ml in the resistant strains.
Biofilm Formation: Biofilm formation was assessed by a variation of the tissue culture
plate method described by Christensen, et. al. (Christensen et al. 1985) with
modifications by Oliveira and Cunha (Oliveira & Cunha 2010) and additional changes to
the timing, medium, the starting inoculum, and the stain used for quantitative assessment.
I prepared cultures of A. baumannii, Ps, 715npRPs, and 718npRPs at 1 x 108 CFU/ml as
described for the MIC test and transferred 0.1 ml to the wells of a flat-bottom, 96-well
culture plate. Since I wanted to determine if the AgNP-resistant strains formed biofilms
more rapidly than the normal strain, I measured the attached cells after 0.5, 2, and 4 hours
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of incubation at 37 C. The unattached cells were removed by dumping the culture plate
and rinsing the wells three times with diH2O. I stained the attached cells and extracellular
polymeric substance with a saturated iodine solution (Lugol’s solution) which I made by
adding iodine crystals, 5% (w/v), to a solution of 10% (w/v) potassium iodide and mixing
vigorously by vortex until no solid iodine was visible. The wells were stained with
Lugol’s solution at room temperature for ten minutes and then dumped, rinsed once with
diH2O and allowed to air dry. I then measured the absorbance of each well at 450 nm
using the SpectraMax plate reader and captured microscopic images using QCapture Pro
6 software (QImaging, Canada) and a QColor 3 camera (Olympus America, NY) which
was attached to an Olympus CKX41 microscope with a 10x objective. I compared the
relative extent of biofilm production between each strain of P. aeruginosa at each time
point both visually and by their absorbance at 450 nm. The biofilm production by P.
aeruginosa was compared to that of A. baumannii as a negative control. The experiment
was conducted one time with 8 replicates of each bacterial strain.
Statistical Analysis: Central tendencies were analyzed and charts created using either the
data analysis tools in Microsoft Excel or Graphpad Prism. Differences between samples
were analyzed by one-way ANOVA followed by Dunnett's Multiple Comparison post
test using Graphpad Prism. Statistical significance was identified by p-values less than or
equal to 0.05 (p ≤ 0.05).

Results
Characterization of AgNPs: The AgNPs were synthesized in three different batches
with maximum light absorbance of 392 nm, 388 nm, and 391 nm (Figures 12e, 2e, and
3e) which corresponded to median diameters of 5.3 nm, 9.4 nm, and 6.3 nm (Table 3,
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Figures 12, 13, and 14). With the three batches combined and 1051 particles measured,
the diameters ranged from 1.0 nm to 25.6 nm with a median of 5.8 nm. The overall
distribution in sizes is displayed graphically in Figure 14f and representative TEM
images from each batch are presented in Figures 12a – 12d, 13a – 13d, and 14a – 14d.
The hydrodynamic diameter, shown in Table 4, is expressed as the Z-average diameter,
which uses the intensity of scattered light from DLS data to calculate a weighted mean. In
water, the Z-average for AgNPs was about 21 nm (± 0.65 nm) and it was slightly larger
in MHB2, ranging from 26 nm to 34 nm between the batches, suggesting that some
agglomeration occurred. The hydrodynamic measurements were obtained using MHB2
with the same composition that was used in the bacterial studies (diluted 1 part stock
MHB2 to 1 part water which contained the test agent). When the stock MHB2 was used
without dilution, the Z-average diameter increased greatly to 915 nm (± 16 nm),
indicating substantial agglomeration in the more concentrated MHB2. This was
confirmed by a typical change in the color of the solution from yellow in water (small,
individual AgNPs are present) to brown in MHB2 (large agglomerates) (Figure 13f). The
zeta potential, or relative surface charge, of the AgNPs was negative 38 mV (± 2.5 mV)
in water and negative 13 mV (± 4.6 mV) in concentrated MHB2 (Table 3). The 3-fold
change in zeta potential indicates a change in solvation or interaction with salts in the
MHB2 which reduced the electrostatic repulsion between nanoparticles and allowed
much greater agglomeration in MHB2. The agglomeration was further confirmed by
TEM images of samples which were dispersed in concentrated MHB2 prior to being
dried on a TEM grid. The TEM analysis revealed agglomerates of particles ranging in
size from 714 to 4722 nm (Figure 15). Interestingly, the zeta potential in dilute MHB2
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was 2-fold less negative than in water but there was much less agglomeration in the dilute
MHB2 which was used for bacterial studies.
The concentration of Ag+ in the stock solution which was measured by separating
the particles from the ions using TFF was about 0.04 g/ml which represented about
0.08% of the total silver in the unconcentrated stock solutions or 0.01% of the total silver
in concentrated solutions. The absorbance spectrum of the TFF filtrate did not show
absorption of light at wavelengths greater than 300 nm, indicating that all of the AgNPs
were preserved in the retentate (Figure 12f).
Batch
max
number (nm)
1
392
2
388
3
391
Combined

DMean (SD)
5.6 (2.2)
9.9 (4.0)
6.3 (2.5)
6.2 (2.7)

Primary Size (nm)
DMedian
5.3
9.4
5.9
5.8

Range
2.1 – 16.6
2.4 – 25.6
1.0 – 17.4
1.0 – 25.6

Table 3: The primary characteristics of the citrate-stabilized AgNPs. The
wavelength of maximum absorbance (max) was determined by using a
plate reader spectrophotometer to measure the absorption spectrum from a
1:10 dilution of the as-synthesized stock solution. The mean and median
diameters (DMean and DMedian) were measured from TEM images using
ImageJ software, SD is the standard deviation of the mean and nm is
nanometers.
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Figure 12: Characterization of the first batch of AgNPs. The representative
images from TEM analysis (a, b, c, d) reveal mostly spherical AgNPs with
diameters ranging from 2.1 nm to 16.6 nm. The AgNP solution was
transferred to a Formvar carbon-coated copper TEM grid and allowed to air
dry prior to imaging. The absorbance spectrum of the AgNPs, diluted 1:10
in water immediately after synthesis, was measured using a plate reader
spectrophotometer. The spectrum showed a fairly symmetrical peak at the
maximum absorbance of 392 nm (e) which was absent when the AgNPs
were separated form Ag+ using TFF (f).
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Figure 13: Characterization of the second batch of AgNPs. The
representative images from TEM analysis (a, b, c, d) reveal mostly spherical
AgNPs with diameters ranging from 2.4 nm to 25.6 nm. The absorbance
spectrum showed a fairly symmetrical peak at the maximum absorbance of
388 nm (e). The TEM and absorbance analysis are described in the legend
for figure 1. The AgNPs produced a yellow color when dissolved in water
but a brown solution when dissolved in MHB2 (f). The vial labeled “W” is
water, “NP W” is AgNPs in water (50 g/ml), “B” is MHB2, “NP B” is
AgNPs in MHB2 (50 g/ml), and “0.1NP B” is AgNPs in MHB2 (50
g/ml).
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Figure 14 Characterization of the third batch of AgNPs. The representative
images from TEM (a, b, c, d) reveal mostly spherical AgNPs with diameters
ranging from 1.0 nm to 17.4 nm. The absorbance spectrum showed a fairly
symmetrical peak at the maximum absorbance of 391 nm (e). The TEM and
absorbance analysis are described in the legend for figure 1.The distribution
in diameters measured from the TEM images for all three batches of AgNPs
had a median value of 5.8 nm (f).
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Figure 15 Images of the agglomeration of AgNPs in concentrated MHB2.
The AgNPs were diluted to 50 g/ml in concentrated MHB2 and incubated
at room temperature for 10 minutes. The solution was then mixed by vortex
and about 10 l was transferred to a Formvar carbon-coated TEM grid and
allowed to air dry. Images of the agglomerated AgNPs were captured by
TEM. Images b, c, e, and f are greater magnifications of the areas indicated
by the yellow boxes in the adjacent image.
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Batch
number

1
2
3

Hydrodynamic diameter (nm)
Z-ave
Z-ave
PDI (SD)
PDI (SD)
(SD)
(SD)
in H2O
in MHB2
in H2O
in MHB2
915* (16) 0.39* (0.04)
21 (0.65) 0.48 (0.003)
33 (0.79)
0.46 (0.03)
18 (0.12) 0.55 (0.002) 26 (0.12) 0.54 (0.001)
19 (0.94) 0.60 (0.04)
34 (1.1)
0.53 (0.03)

Zeta potential (mV)
Mean in
Mean in
water
MHB2
(SD)
(SD)
-38 (2.5)

-13* (4.6)

-28 (2.3)
NT

-14 (3.8)
NT

Table 4: The hydrodynamic characteristics of the citrate-stabilized AgNPs.
The Z-average diameter (Z-ave) and the polydispersity index (PDI) in
water and MHB2 were measured using dynamic light scattering and the
zeta potential was measured by laser Doppler micro-electrophoresis. Each
value is the mean and standard deviation (SD) of three tests. NT means not
tested, mV is millivolts, and nm is nanometers. The asterisk (*) indicates
values that were generated using more concentrated MHB2 (not diluted to
the strength used in antibacterial studies). Hydrodynamic measurements
were not obtained for batch 2.
Antibacterial Efficacy (MIC and MBC): The antibacterial efficacy of AgNPs was
assessed by micro-dilution MIC and MBC studies. The Gram negative organisms, P.
aeruginosa and A. baumannii, were more sensitive to AgNPs than S. aureus, the Gram
positive bacterium (Table 5). The two Gram negative bacteria were also more sensitive to
AgNO3 than S. aureus and more sensitive to AgNO3 than to AgNPs. The Gram positive
S. aureus was more sensitive to BZC than the two Gram negative organisms. Cipro was
highly effective against all three bacteria. The MBC was generally the same or 2-fold
greater than the MIC for each test agent. Sodium citrate was also tested and it did not
inhibit bacterial growth at concentrations up to 1.7 mM, which is more than 10-fold
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greater than the concentration used for AgNP synthesis (data not shown). There was no
difference in the MIC or MBC values between the three batches of AgNPs.

P. aeruginosa
Agent

MIC MBC
(g/ml) (g/ml)

MBC/MIC

A. baumannii
MIC

MBC

(g/ml)

(g/ml)

S. aureus

MBC/MIC

MIC

MBC

(g/ml)

(g/ml)

MBC/MIC

AgNPs 3.75

7.5

2

1.88

3.75

2

15

60

2

AgNO3 1.88

3.75

2

0.47

0.94

2

7.5

30

4

Cipro

0.12

0.23

2

0.23

0.47

2

0.12

0.23

2

BZC

30

60

2

7.5

15

2

0.94

1.88

2

Table 5: The MIC and MBC of test agents. The MIC and MBC of
ciprofloxacin (Cipro), benzalkonium chloride (BZC), silver nitrate
(AgNO3), and citrate-stabilized AgNPs were tested against Pseudomonas
aeruginosa, Acinetobacter baumannii, and Staphylococcus aureus in
micro-dilution assays; g/ml is micrograms per milliliter and MIC/MBC is
the dividend of the MIC and MBC; each value represents the median of 8
to 30 tests.
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Agent
AgNPs
AgNO3
Cipro
BZC

Exposures Tolerated by Each Organism
P. aeruginosa
A. baumannii
S. aureus
Still inhibited by the
Still inhibited by the
Growth at 400% of
MIC in step 9
the MIC by step 2 or 3 MIC in step 9
Growth at the MIC in
Growth at the MIC in
Growth at 340% of the
step 9
step 9
MIC in steps 5 – 9
Growth at 400% of
Growth at 400% of
Growth at 400% of
the MIC by step 3
the MIC by step 4
the MIC by step 8
No growth by step 2
Growth at the MIC in
Growth at the MIC in
(eliminated at ½ the
step 9
step 9
MIC)

Table 6: Stepwise resistance development test results. The development of
resistance was tested by a stepwise increasing exposure model. Each pair
of bacterium and agent was tested at least twice. The results, relative to the
MIC, are listed for exposures that resulted in resistance (bold) or the
greatest tolerable concentration after nine experimental steps. Resistance
was defined by growth at 400% of the MIC (4-fold greater concentration
than the MIC).
Resistance Development: The development of resistance to AgNPs, Cipro, BZC, and
AgNO3 was studied using a stepwise increasing exposure model in which the bacteria
were exposed to the test agents at 0.25-, 0.5-, 1.0-, 1.25-, and 1.5-fold multiples of the
MIC and subsequent tolerable concentrations. Resistance was defined as growth in a
concentration that was 4-fold greater than the original MIC. All three of the bacteria
tested developed resistance to Cipro, but only P. aeruginosa developed resistance to
AgNPs (Table 6). Cipro-resistance developed relatively quickly in P. aeruginosa (step 3)
and A. baumannii (step 4) in each of the two tests for each organism, but it did not
develop as rapidly in S. aureus (step 8). The AgNP-resistance that developed in P.
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aeruginosa was equally as rapid (2 or 3 steps). None of the bacteria developed resistance
to BZC or AgNO3. While S. aureus was able to tolerate AgNO3 at 22 g/ml, or 340% of
the MIC by step 5 of the test, greater concentration inhibited its growth in steps 5, 6, 7, 8,
and 9, which prevented resistance from developing. It is worth noting that in 2
preliminary studies in which 0.5-, 1-, and 2-fold multiples of the MICs and tolerable
concentrations, P. aeruginosa was eliminated by AgNO3 in the second step of the study,
and AgNPs eliminated the bacteria by the third step. The bacteria could only develop
resistance to silver, therefore, when the concentration was sufficiently low or and the
stepwise increase in concentration was relatively small.
When the MIC and MBC for AgNPs, AgNO3, Cipro, and BZC were tested on at
least three different frozen aliquots of the AgNP-resistant strains (715npRPs and
718npRPs), AgNP-resistance was found to be stable. Cross-resistance to AgNO3 was also
discovered in one strain, but there was no cross-resistance to Cipro or BZC (Table 7).
Resistance to AgNPs was also stable when the bacteria underwent daily, serial transfer in
MHB2 for up to 9 days (Table 8). The highest concentration of AgNPs tested prior to the
serial transfer studies was 90 g/ml, because more concentrated solutions were not
available at that time. Since the resistant strains were inhibited at that concentration, the
actual MIC and MBC values were greater than 90 g/ml, but could not be determined
with more accuracy. When the serial transfer studies were completed, a more
concentrated solution was available and more accurate MIC and MBC values were
determined. The MIC decreased slightly after serial passage for both the resistant and
normal strains of P. aeruginosa, which could suggest a general change in growth
characteristics during serial passage. One change which was noted during the stepwise
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increasing exposure experiments was the formation of a thick, mucoid-like substance
after 2 to 3 days of passage. Vigorous mixing was required to disperse the substance and
preserve the correlation between cell density and optical density which was used to
standardize the inoculum for each step. Mucoid secretions are a common characteristic of
some P. aeruginosa strains and contribute to biofilm formation (Yang et al. 2011).
Biofilm production is known to reduce the susceptibility of P. aeruginosa to many
antibacterial agents by a poorly understood mechanism (Hoiby et al. 2010; Mah &
O’Toole 2001). Differences between the three strains of P. aeruginosa in the production
of a biofilm might, therefore, contribute to resistance; however, there was no obvious
difference between the strains. In addition, I noted color differences when P. aeruginosa
was grown on agar (Figure 16a) or during serial transfer in MHB2 (Figure 16b, c, and d).
When cultured overnight on agar and during the first two passages in MHB2, the
718npRPs strain and normal P. aeruginosa had a yellow-green color, and 718npRPs
maintained that color during serial passage. The normal P. aeruginosa, however,
produced a blue-green color during passages 3 through 9 in MHB2. The 715npRPs strain
produced the blue-green color variation on agar and maintained it throughout the serial
passages in MHB2. The different colors originate from phenazine pigments which are
another common feature of P. aeruginosa. The pigments are involved in nutrient
acquisition and quorum sensing, which also contributes to biofilm formation (Adonizio et
al. 2008; Evans et al. 1998). The production of phenazine pigments, therefore, might also
contribute to resistance, but the color variation was not the same between the two
resistant strains, and so there might be different resistant mechanisms involved.
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P. aeruginosa
Agent

715npRPs

718npRPs

MIC

MBC

MIC

MBC

MIC

MBC

(g/ml)

(g/ml)

(g/ml)

(g/ml)

(g/ml)

(g/ml)

AgNPs

3.75

7.5

>90

>90

>90

>90

AgNO3

1.88

3.75

3.75

30

30

30

Cipro

0.12

0.23

0.12

0.24

0.23

0.12

BZC

30

60

60

60

60

60

Table 7: The MIC and MBC of test agents against normal and AgNPresistant P. aeruginosa. The MIC and MBC of Cipro, BZC, AgNO3, and
AgNPs were tested against the normal and two resistant strains of P.
aeruginosa using at least three different frozen aliquots.
P. aeruginosa
Agent

715npRPs

718npRPs

P0 MIC

P9 MIC

P0 MIC

P9 MIC

P0 MIC

P9 MIC

(g/ml)

(g/ml)

(g/ml)

(g/ml)

(g/ml)

(g/ml)

AgNPs

3.75

0.94

>90

120

>90

90

AgNO3

1.88

0.23

3.75

1.88

30

9.4

Cipro

0.12

0.12

0.12

0.12

0.23

0.12

BZC

30

30

60

30

60

60

Table 8: The MICs and MBCs of test agents against P. aeruginosa after
serial passage. The MICs of Cipro, BZC, AgNO3, and AgNPs were
determined against normal and AgNP-resistant P. aeruginosa before (P0)
and after (P9) daily, serial passage in MHB2.
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Figure 16: The change in pigments produced by P. aeruginosa during serial
transfer. Normal (labeled Ps) and AgNP-resistant strains (labeled 715 and
718) were cultured overnight on agar and then transferred to MHB2 for
daily, serial passage. The blue-green color of 715 and the yellow-green
color of 718 were consistent throughout the experiment, but the color of Ps
was similar to 718 on agar (a) and in the first serial passage (b), but by serial
passage five (c) and continuing through passage 9 (d), Ps was more similar
in color to 715.
The Mechanism of Resistance: I tested the potential mechanisms for resistance to AgNP
based on the assumption that AgNPs must release Ag+ through dissolution in order to
effectively inhibit bacterial growth. The lack of cross-resistance to Cipro (Table 7)
suggests that membrane permeability and efflux are not involved in the resistance to
AgNP because those mechanisms often confer resistance to quinolone antibiotics like
Cipro (Henrichfreise et al. 2007; Lambert 2002; Redgrave et al. 2014). I tested efflux as a
mechanism to limit the intracellular dose of Ag+ by measuring the internalization of
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membrane-permeable, fluorescent dyes between the normal and AgNP-resistant strains of
P. aeruginosa. I also did not find a difference in the efflux of fluorescent dyes between
the normal and resistant strains, confirming that efflux did not contribute to resistance
(Figure 17). The uptake of each fluorescent dye was greater at 4 C than at 37 C, which
verified that changes in the intracellular localization of each dye was affected by an
energy-dependent process, such as efflux. The efflux of acridine orange was inhibited at
4 C for concentrations up to 1.25 g/ml, but above 2.5 g/ml, less dye was internalized
at 4 C than at 37 C. The fluidity of the bacterial membrane is presumed to decreases
when a bacterium that has acclimated to a warm temperature is moved to low
temperatures due to the tight packing of saturated lipids at the lower temperatures (Klein
et al. 1999; Mrozik et al. 2004; Sinensky 1974), and low fluidity causes a decrease in
permeability (Lande et al. 1995). Since acridine orange was the only dye with an
unexpected flip in the relative uptake between 4 C and 37 C, the presumed change in
membrane fluidity may have affected its permeability more than the other dyes. Since
Hoechst 33342 had the most dramatic change in fluorescence (Figure 17a, between 2.5
and 5 g/ml), a second study was conducted at higher concentrations to see if differences
in efflux between strains would become apparent. There was, however, no difference
between the normal and AgNP-resistant strains at the higher concentrations (Figure 18),
which suggests that membrane permeability and efflux were not involved in resistance to
AgNPs.
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Figure 17: The efflux of membrane-permeable, fluorescent dyes by P.
aeruginosa. Cultures of normal (normal Ps) and AgNP-resistant
(715npRPs) strains of P. aeruginosa were incubated with different
concentrations of (a) Hoechst 33342 (Hoechst) or ethidium bromide (EB),
or (b) acridine orange (AO) for 1 hour at 37 C to encourage efflux or at 4
C to inhibit efflux and then their relative fluorescence was measured.
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Figure 18: The efflux of membrane-permeable Hoechst 33342 dyes in the
different strains of P. aeruginosa. Cultures of normal (normal Ps) and
AgNP-resistant (715npRPs and 718npRPs) strains of P. aeruginosa were
incubated with Hoechst 33342 for 10 minutes at 37 C and then their relative
fluorescence was measured.
I used a common tissue culture plate method to test for biofilm formation, which
could limit the amount of AgNPs and Ag+ that reach the bacterial cells. In the method,
the bacteria are normally incubated for one or more days to allow biofilm formation, but I
chose to use shorter time points because P. aeruginosa is already known to form biofilms
during longer incubations. In order for the biofilm to contribute to resistance under the
condition that I used here to produce and test for resistance, the biofilm must begin to
form early, for example as soon as the silver is added to the culture. At the earliest time
point (0.5 hours), I observed deposits in each of the wells that contained P. aeruginosa
and A. baumannii (Figure 19b-e), but at 2 hours the deposits in the A. baumannii wells
were significantly reduced (Figure 19g), and by 4 hours the A. baumannii wells (Figure
19l) looked similar to the “no cell” control (Figure 19k), confirming that A baumannii
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was not forming a biofilm at those time points. The wells containing the normal strain of
P. aeruginosa appeared similar to A. baumanni at the earliest time point (Figure 19c), but
thereafter (Figure 19h, m) were similar to the AgNP-resistant strains of P. aeruginosa
(Figure 19i, j, n, o). The two resistant strains appeared slightly different from each other
at 0.5 hours: 718npRPs appeared to have a layer of closely packed cells (Figure 19e,
white spots) while the deposits in the 715npRPs wells appeared less densely packed
(Figure 19d). In fact, the biofiolm deposit appeared to be greater than normal P.
aeruginosa, but less than 718npRPs. After 4 hours, the bottom of the wells containing P.
aeruginosa were noticeably darker than the wells in which A. baumannii was cultured
(Figure 19l-o). Spectral analysis confirmed that there was no biofilm formation
associated with A. baumannii, but that each of the P. aeruginosa strains had significant
staining, in other words biofilm formation, by 4 hours (Figure 20). There was no
difference, however, between the P. aeruginosa strains at any of the time points,
suggesting that biofilm formation did not contribute to AgNP resistance. The iodine
which I used should preferentially stain the extracellular components of a bacterial
biofilm, and so the visual difference in deposits on the bottom of the culture wells (Figure
19) may have been caused by cells which attach to or grow inside of the biofilm. The
cells themselves should not be stained by iodine, and therefore the spectral analysis is
more descriptive of biofilm formation than the visual observations.
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Figure 19: Representative images of biofilms produced by the different
strains of P. aeruginosa. Normal P. aeruginosa (c, h, and m), 715npRPs (d,
I, and n), 718npRPs (e, j, and o) and A. baumannii (b, g, and l) were seeded
to the wells of a tissue culture plate and cultured for up to 4 hours. The wells
were stained with iodine, rinsed, and then air-dried in order to determine if
the extracellular deposits which are typical of biofilms were present. The
wells containing A. baumannii appeared to form deposits early (b and g) but
appeared the same as the no cell control (a, b, and k) by the 4 hour time
point (l). The appearance of deposits formed by the normal and AgNPresistant P. aeruginosa stains were different at 0.5 hours (c, d, and e), but
they appeared the same by 2 hours (h, i, and j) and 4 hours (m, n, and o).
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Figure 20: The results of the spectral analysis of P. aeruginosa biofilms
stained with iodine. Early biofilm formation was quantified by culturing A.
baumannii (negative control) and each strain of P. aeruginosa in a tissue
culture plate and then staining the wells with iodine after 0.5, 2, or 4 hours.
The absorbance of each well at 450 nm was then measured in order to
determine how much extracellular material was deposited. Iodine staining
for A. baumannii was not different from the “No Cells” control at each time
point. The P. aeruginosa wells were not different from the controls at 0.5
and 2 hours, but they increased at 4 hours. The normal and resistant strains
of P. aeruginosa did not differ from each other. The difference in
absorbance was analyzed by ANOVA with Dunnet’s Multiple Comparison
post-test. An asterisk (*) indicats significant difference from the “No Cells”
control (p ≤ 0.05).

75

Discussion
The increased use of AgNPs as antibacterial agents, especially in wound
management, has raised concerns over the potential for resistance to develop. This study
revealed a realistic potential for P. aeruginosa to develop resistance to AgNPs. The
bacterium developed a stable resistance to AgNPs as rapidly as it developed resistance to
Cipro; however, it required a sufficiently low concentration of silver and relatively small,
stepwise increase in concentration in order for P. aeruginosa to adapt to the presence of
silver. Those conditions may, or may not be relevant in wound treatment situations since
wound dressings are changed periodically to optimize healing.
The mechanism by which P. aeruginosa developed resistance is not yet clear, but
several potential mechanisms exist, including decreased membrane permeability through
down-regulation of the outer membrane porins, increased efflux through up-regulation of
efflux systems, alteration of the antibacterial target, biofilm formation, and producing
molecules that alter the antibacterial agent (Lambert 2002). As discussed in the
introduction to this thesis, the antibacterial mechanism for AgNPs appears to depend on
the release of Ag+ (Xiu et al. 2012), and so the mechanisms of resistance to AgNPs is
likely based on the ability of P. aeruginosa to limit its exposure to Ag+. Membrane
permeability and efflux can each reduce the intracellular dose of Ag+. I did not find a
difference in the internalization of membrane-permeable, fluorescent dyes, which has
been used by others to determine the capacity for bacteria to extrude antibacterial agents
(Brenwald et al. 1998; Coldham et al. 2010; Martins & Amaral 2012; Martins et al. 2011;
Richmond et al. 2013). I assumed from the increased uptake of the dyes at low
temperature that I was measuring intrinsic efflux capacity; however, the fluidity of the
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bacterial membrane decreases as the temperature decreases which can also reduce the
permeability of the membrane to non-polar molecules (Lande et al. 1995; Panja et al.
2008). Efflux should be studied further as a resistance mechanism by measuring the
amount of silver taken up by bacterial cells and differences in the rate at which silver is
extruded from the cells after being internalized. Chemical inhibitors of efflux such as
reserpine or verapamil should be used to strengthen the association between changes in
silver content and efflux.
Biofilm formation may protect bacterial communities form bactericidal agents
(Hoiby et al. 2010). I did not find a difference in biofilm formation between the normal
and AgNP-resistant bacteria; however, biofilm analysis is typically conducted over a
longer time period (Christensen et al. 1985; Oliveira & Cunha 2010). Since Ag+ is a
relatively potent bactericidal agent, a biofilm would have to form very rapidly to protect
the bacteria from exposure. Thick, mucoid-like substances and visible chunks were noted
in the cultures of each of the P. aeruginosa strains, but only after 6 to 8 hours of culture,
and there was no difference noted between strains. The production of exopolysaccharides
such as alginate or “polysaccharide from polysaccharide synthesis locus” (Psl) (Colvin et
al. 2012) or quorum sensing molecules such as N-(3-oxododecanoyl)-L-homoserine
lactone and N-buyanoyl-L-homoserine lactone (Adonizio et al. 2008) should be measured
in order to fully reject the involvement of biofilms in silver resistance.
There is a real potential for the phenazine pigments that are produced by P.
aeruginosa to protect the bacterium from exposure to silver. Some of the phenazine
pigments function as siderophores to bind and transport trivalent iron (Fe3+) into the
bacterial cells, while others are redox active and can reduce Fe 3+ to the more soluble Fe2+
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to facilitate iron uptake (Cornelis & Dingemans 2013). The most common siderophores
produced by P. aeruginosa are pyochelin, which can bind many metal ions including Ag+
(Braud et al. 2009), and pyoverdin, which does not appear to bind Ag+ (Bhattacharya
2011). P. aeruginosa can switch between its siderophores in response to iron availability
in its environment (Cornelis & Dingemans 2013; Dumas et al. 2013), and since only one
siderophores can bind Ag+, changing which siderophore is produced might alter the
sensitivity of the bacterium to silver. In addition, pyocyanin is a redox active phenzaine
that is commonly produced by P. aeruginosa, and Muller and Merrett (Muller & Merrett
2014) recently reported that pyocyanin can reduce Ag+ to Ag0 and protect the bacteria
from silver-mediated inhibition. I noticed a difference in the color produced by each
strain of P. aeruginosa: the normal P. aeruginosa produced a yellow-green color on agar
and during the first 2 daily serial passages, which could be pyochelin or pyoverdin, but
produced a blue-green color thereafter, which is most likely pyocyanin. The pattern
observed is typical of P. aeruginosa in culture because pyocyanin production is normally
low until the stationary phase of growth when iron availability is low (Dergez et al. 2014;
Frank & DeMoss 1959). The 715npRPs strain produced the blue-green color variation on
agar and maintained it throughout serial passage, which suggested that the amount of
pyocyanin produced by that strain was high throughout its life cycle. If pyocyanin is
reducing the Ag+ that are released by the AgNPs to a less bioavailable Ag0, then
increased, early pyocyanin production might be the resistance mechanism for 715npRPs;
however, the same mechanism should protect the bacteria form AgNO 3, but that strain
was not cross resistant to AgNO3 (Table 7). The 718npRPs strain maintained a yellowgreen color on agar and throughout serial passage, which indicates that it did not switch
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to pyocyanin production in stationary phase. If that strain produces more pyochelin than
the normal strain and does not switch to an alternate iron-uptake mechanism later in its
lifecycle, then the pyochelin could bind Ag+ and render it unavailable for bactericidal
activity. That strain was cross-resistant to AgNO3, which would be consistent with a
pyochelin-based mechanism; however, since the function of pyochelin is to transport iron
into the cell, it seems logical that it would also transport Ag+ into the cell and that is
counterintuitive toward a resistance mechanism. Additional studies into the production of
phenazine pigments and their effect on Ag+ bioavailability are necessary in order to
understand their potential role in resistance to silver.

Conclusion for section 2
This study demonstrated that AgNPs have a lower potential for resistance
development than Cipro, but AgNO3, which was a more potent antibacterial agent than
AgNPs, had even less potential for resistance to develop. In wound management, bacteria
inhibit wound closure mainly by causing chronic inflammation which increases the
expression of matrix degrading enzymes and decreases the expression of growth factors
that are necessary for wound closure (Edwards & Harding 2004; Sibbald et al. 2007).
Effective elimination of bacteria from the wound will improve healing (Wright et al.
2002). Silver is an effective antibacterial agent, and the 3 species of bacteria tested in this
study were relatively sensitive to Ag+ from AgNO3 and to AgNPs, but AgNO3 was
clearly more potent than AgNPs, which has already been described in the literature (Choi
et al. 2008; Percival et al. 2007). The Gram negative bacteria (P. aeruginosa and A.
baumannii) were more sensitive to both AgNO3 and AgNPs than the Gram positive (S.
aureus), which has also been reported by others (Chudasama et al. 2010; Jung et al. 2008;
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Khan et al. 2014; Kim et al. 2007; Sintubin et al. 2011; Szczepanowicz et al. 2010). The
difference in susceptibility is believed to be related to the greater susceptibility of the
Gram negative outer membrane than the thick proteoglycan layer over the Gram positive
bacteria (Feng et al. 2000; Jung et al. 2008). Since both AgNO3 and AgNPs are effective
antibacterial agents, the advantage of one over the other in wound management might
derive from their relative potential for resistance development. In this study, none of the
bacteria developed resistance to AgNO3 but P. aeruginosa developed resistance to
AgNPs. It seems that the immediate bioavailability of Ag+ might be important for
efficient bactericidal activity, and so it might be more advantageous to use AgNO 3
instead of AgNPs in wound dressings.
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THESIS CONCLUSION
The goal of this thesis was to evaluate the benefit of using AgNPs in wound
management based on their potential for resistance development, and the hazard of using
them based on their potential to cause long-term stress in mammalian cells. The first
section of the thesis demonstrated that AgNPs have the potential to cause long-term
redox imbalance and induce premature cellular senescence. While it seems logical that
cellular senescence would have a negative impact on the long-term health of the tissue,
the impact of senescence on wound resolution is not well understood. Never-the-less, any
long-term effects on tissues should have been apparent from the use of commercially
available dressings that containing AgNPs, but none have been reported to date. Fong and
Wood (Fong & Wood 2006), wrote an extensive review of the dressings available in
2006 that contained AgNPs. They reported that dressings that incorporated AgNPs were
superior to other dressings due to less frequent changes of the dressing, less pain reported
during dressing changes, and fewer complications during wound resolution. They also
pointed out that proper use of the AgNP-containing dressings would prevent resistance
development and any potential toxicity involving human cells in the wound. No negative
effects on the wound-associated tissues were reported in a more recent review (Wilkinson
et al. 2011) which pointed out that silver in any form has a history of minimal in vivo
toxicity and that is why it has a long history of use as an antibacterial agent. Still, it is
possible that the health of wound-associated tissues was not assessed in follow-up
evaluations where silver was used in wound management. Wound resolution was the
primary concern and not the long-term impact that the treatment might have on the
surrounding tissue. Since the first section of this thesis demonstrated a clear potential for
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a long-term, negative effects that could impact the health and function of tissue, caution
should still be exercised and additional studies with proper follow up evaluations are
necessary. The structure and function of the surrounding tissue should be evaluated in
order to reveal any negative impact that the silver-containing dressings may have had on
wound closure and tissue remodeling.
The studies discussed in the introduction to this thesis show that the principle
hazard associated with AgNPs is not from direct exposure to the particles but from the
release of Ag+ after the particles are internalized by a cell. The experiments conducted in
section one did not directly test if the particles or the ions were responsible for the
cellular changes observed. The studies did demonstrate the persistence of AgNPs in the
cells after silver-containing medium was replaced with silver-free medium, and the
cellular effects of oxidative stress, increased SA--Gal, and hypertrophic morphology
were each observed up to three days after the AgNPs were removed. The dissolution of
AgNPs over time is well known, and the increased release of Ag+ in the acidic
environment of lysosomes, the cellular compartment where AgNPs are sequestered once
internalized, has been described for the same AgNPs used for these experiments (Maurer
et al. 2014). It is highly likely, therefore, that each of the observed effects was cause by
Ag+ that was released after the AgNPs were internalized. The Ag+ is not as toxic to
mammalian cells prior to internalization because they form insoluble salts and are no
longer bioavailable (Drake & Hazelwood 2005). In order to take full advantage of the
antibacterial properties of Ag+ and the extended release properties of AgNPs and avoid
the “Trojan horse” (Park et al. 2010) consequence of internalizing AgNPs, the particles
should be embedded in the dressing so that mammalian cells at the wound site will only
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be exposed to the Ag+ that is released. That can be accomplished by placing the AgNPs
behind a membrane through which wound exudate will pass and provide moisture into
which Ag+ can dissolve. The dissolved Ag+ would then diffuse from the bandage into the
wound area and prevent bacterial invasion, but should precipitate as AgCl or Ag2S prior
to affecting the mammalian cells. The effectiveness of such a design would depend upon
the amount and nature of exudate produced by the wound. If too little exudate is
produced or its fluid content is too low, the amount of silver diffusing from the dressing
might be too small to control bacterial growth. Section two of this thesis demonstrated
that when the concentration of AgNPs is too low, P. aeruginosa can develop a stable
resistance to them and complicate the resolution of that wound. The mechanism of
resistance which developed in this study was not determined, but appears to be related to
silver redox (pyocyanin) or chelation (pyochelin). An organism in the wound that can
reduce the bioavailability of Ag+ in a similar way would not only protect itself but would
inadvertently protect the other organisms that are present. The potent antibacterial
activity of AgNO3 that was observed in this study and the immediate availability of all
the Ag+ present make it a better choice for wound management, but since all the Ag+ is
released to the wound immediately, it would require more frequent dressing changes in
order to maintain an effective Ag+ concentration (Atiyeh et al. 2007). The most effective
treatment would most likely result from a dressing that contained both AgNO 3 for an
immediate bolus of Ag+ and AgNPs (sequestered behind an ion-permeable membrane) to
release additional ions over an extended period of time.
In conclusion, AgNPs are an effective antibacterial agent for use in wound
management and have a reduced potential for resistance to develop; however, their

83

potential to cause detrimental effects once internalized by mammalian cells demands that
additional studies be conducted to better define those effects and determine how they
impact wound resolution and the long-term health of tissues. The more potent
antibacterial activity of AgNO3 and its lower potential for resistance development
compared to AgNPs make it even better for short-term wound management. The
combination of AgNPs whose release from the dressing is limited and AgNO3 which
provides a bolus of Ag+ is probably the most advantageous approach for wound
management.
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